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This thesis focuses on the use of hydrogel nanoparticles as cancer cell targeting 
delivery vehicles. Chapter 1 gives a detailed background of hydrogels and their many 
uses.   Chapter 2 describes the use of AFFF-MALLS to investigate the characteristics of 
microgels. Chapter 3 details nanogel synthesis and their bioconjugation. The nanogels 
were designed to be ideal drug delivery vehicles, in terms of size and targeting capability. 
These particles are the focus of the remaining chapters. 
Chapter 4 details the encapsulation and delivery of siRNA to ovarian cancer cells. 
High siRNA loading levels are seen in the particles, as well as effective transport into the 
cells. Protein silencing by the nanogel delivered siRNA is then described in Chapter 5. 
The protein silencing leads to apparent increased cancer cell toxicity after subsequent 
chemotherapy delivery. Successful in vitro targeting led to in vivo delivery of nanogels, 
described in Chapter 6. The nanogels were used to deliver silver nanoclusters to 
Matrigel
TM
 plugs in mice. Chapter 7 lists the future experiments that should be done on 










INTRODUCTION TO HYDROGELS AND THEIR USE AS 
BIOMATERIALS 
 
Adapted from Singh, Neetu; Blackburn, William H.; and Lyon, L. Andrew. 
“Bioconjugation of Soft Nanomaterials”, Biomedical Nanostructures, John Wiley & 
Sons, Inc, 2008, 61-91. 
  
1.1 Introduction 
 The last decade of research in the physical sciences has seen a dramatic increase 
in the study of nanoscale materials, and in their application to problems in biotechnology. 
The intriguing optical, electrical, magnetic, and mechanical properties of many 
nanostructures can be exploited for sensing, imaging, and therapeutics. However, much 
of the work has focused on “hard” materials such as carbon nanostructures, magnetic 
materials, metals, and semiconductors, since these are the materials that display the most 
profound and advantageous nanoscale phenomena. Despite the continued interest in these 
established areas of nanoscience, new classes of soft nanomaterials are being developed 
from more traditional polymeric constructs. Specifically, nanostructured hydrogels and 
their conjugates with biomolecular entities are emerging as a promising group of 
materials for multiple biotech applications. This chapter will present some of the recent 
advances in the marriage between bioconjugated, nanoscale, water-swellable networks 
and the biosciences. 
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The relevance of “nano” to a soft material can be very different from that of an 
optically, magnetically, or electrically active material, since most hydrogels are mainly 
interesting from a structural or physicochemical standpoint. Therefore, the goal of this 
chapter is simply to explore current research in polymeric hydrogel particles, where the 
nanoscale dimensions of the hydrogel have particular relevance to the length scales of the 
biological system under study. The focus on polymer particles is important, as these 
discrete structures bridge the gap between more traditional areas of nanoscience and the 
world of soft matter. The focus on hydrogels arises from the growing need to understand 
how hydrophilic polymers can impact emerging areas of biotechnology. 
 
1.1.1 Definition of Hydrogels 
 As a classification of materials, gels escape a rigid definition as they combine the 
properties of solids and fluids. They have structural integrity and do not flow when 
removed from their container. However, for molecules that are significantly smaller than 
the gel pore size, the transport of material through a gel is similar to mass transport in a 
homogeneous fluid. Hydrogels, as the name implies, are gels that swell in aqueous media. 
They are composed of a hydrophilic polymer component that is cross-linked into a 
network by either covalent or non-covalent interactions.
[1-3]
 Cross-linking provides 
dimensional stability, while the high solvent content gives rise to the fluid-like transport 
properties. The particular physical properties associated with these materials make 
hydrogels ideal candidates for a number of applications. Perhaps their most widespread 
use is in superabsorbent materials, which simply absorb and entrap water as in baby 
diapers. However, to make an impact in areas such as in vivo diagnostics, drug/gene 
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delivery, chemical separations, or chemical and biological sensors, many groups have 
pushed towards the synthesis of more complex polymer architectures that often contain 
one or more biomolecular components. In this chapter, we will focus on a wide variety of 
approaches towards bioconjugated, hydrogel nanomaterials. For example, tremendous 
progress has been made in the assembly of amphiphilic block co-polymers into 
dimensionally stable micellar particles. We will also address the use of stimuli-sensitive 
polymers in such materials, as these polymers offer new routes to hydrogels that can 
sense and respond to local environmental conditions, thereby interfacing with biology in 
an active fashion. 
 
1.1.2  Classification of Hydrogels 
Hydrogels can be classified in many ways but in this chapter, they will be dealt 
with in terms of gel formation. Based on the type of gels there are two classes of 
hydrogels. The following sections will describe macrogels and microgels, with the main 
focus of this chapter being on microgels.  
 
1.1.2.1 Macrogels 
The most typical form of a hydrogel is in a macroscopic form.
[4-6]
 These “bulk” 
gels can be anywhere from millimeters in dimension or larger. Macrogels can be further 
classified based on the types of cross-links that connect the gels. Based on the type of 
cross-links there are two classes of hydrogels.
[7]
 For more detailed information on non-






1.1.2.1.1 Physically Cross-Linked Hydrogels 
Hydrogels containing non-covalent cross-links fall under this definition. Such 
networks give rise to reversible or degradable materials that undergo a transition from the 
three-dimensionally stable network to a polymer solution upon changing the solution 
conditions (e.g. temperature, ionic strength, pH, solvent identity). These types of 






 and then release 
them by dissolution of the hydrogel structure. One or more types of non-covalent 
interactions can hold these hydrogels together. These forces are often hydrophobic, 
hydrogen bonding, or ionic associations. 
An example of an ion-sensitive gel is alginate, which is a polysaccharide 
composed of mannuronic acid and gluconic acid. The polymer chains can be cross-linked 
by divalent calcium ions,
[7, 12]
 after which hydrogel can be dissolved by using a chelating 
agent such as EDTA. Alginate hydrogels have been used for encapsulating proteins and 
also as a matrix for the encapsulation of cells, often allowing for growth and proliferation 
of the cells within the encapsulating gel. Another example of cross-linking by ionic 
interactions is that of dextran, which lacks charged regions, but forms hydrogels in the 
presence of potassium ions; six oxygen atoms of glucose units on three adjacent polymer 
chains act to chelate potassium, thereby forming a network.
[13]
  
 Blends and interpenetrating networks between two dissimilar polymers can also 
form non-covalent cross-links. For example, poly(acrylic acid) and poly(methacrylic 
acid) form hydrogen bonds with poly(ethylene glycol). The hydrogen bond is formed 
between the oxygen of the poly(ethylene glycol) and carboxylic group of the poly acids. 
The hydrogen bonds are formed only when the acid groups are protonated, hence 
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hydrogel formation is pH triggered.
[14, 15]
 Oligonucleotides have also been used in the 
formation of hydrogels. Nagahara et al. coupled water soluble poly(N,N-
dimethylacrylamide-co-N-acryloylsuccinimide) to a single stranded DNA.
[16]
 At room 
temperature and in presence of complementary DNA, hydrogels are formed, which then 
dissolve at temperatures above the DNA melting point. 
 
1.1.2.1.2 Chemically Cross-Linked Hydrogels 
Chemically cross-linked gels are usually formed by polymerizing monomers in 
the presence of cross-linking agents.
[7]
 Poly(2-hydroxyethyl methacrylate) is a well 
studied hydrogel-forming polymer. It is typically synthesized by polymerizing 2-hydroxy 
methacrylate with ethylene glycol dimethacrylate as a cross-linker. Various physical 
properties, such as the swelling capacity of the hydrogels are controlled by the amount of 
cross-linker used.
[7]
 Hydrogels can also be formed by cross-linking of the various 
functional groups present on the polymer backbone. Polymers containing hydroxyl, 
amine or hydrazide groups can be cross-linked by using glutaraldehyde, which forms 
covalent bonds with each of the above-mentioned functionalities.
[7, 17, 18]
  
Enzymes have been used in the formation of cross-linked hydrogels. In one 
interesting example, Sperinde et al. employed tetrahydroxy PEG functionalized with 
glutaminyl groups. This polymer forms hydrogels in the presence of an enzyme 
transglutaminase and poly(lysine-co-phenylalanine), where the enzyme catalyses the 
reaction between the γ-carboxyamide group of the PEG-glutaminyl polymer and ε-amine 






1.1.2.2 Microgels and Nanogels 
The subject of this chapter is largely related to entities smaller than macrogels, 
which are typically called microgels.
[21, 22]
 Microgels are colloidally stable hydrogels 
whose size can vary from tens of nanometers to micrometers. Perhaps the earliest report 
of microgel synthesis was by Staudinger in 1935,
[23]
 but interest in such materials for 
biotechnology applications has only flourished recently. For recent reviews on the subject 







1.1.3 Stimuli-Sensitive Polymers 
A large body of research has recently been devoted to the study of gels that 
respond to their environment; such materials offer the possibility to design tunable or 
triggered devices.  These stimuli-responsive gels are often called “smart” materials, as a 
result of their responsivity.
[26, 27]
 However, such a moniker is unwarranted, as the gel 
behavior can be simply described as a polymer phase transition or phase separation. 
There is no more “intelligence” in these materials than that of a melting ice cube. 














 The responsive behavior of the hydrogels is inherited from the type of 
the polymer used in making the gel and/or any modifications made post-polymerization. 
The use of stimuli-sensitive polymers in fabricating hydrogels has led to many 
interesting applications, including those using bioconjugated materials; in this section we 
will discuss some fundamentals of stimuli-responsive materials to lay the groundwork for 
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later discussions. One of the most widely studied stimuli-sensitive polymers is poly(N-
isopropylacrylamide) (pNIPAm) formed from the monomer N-isopropylacrylamide. 
Since a great deal of work done in our group has been based on pNIPAm, and also to 
facilitate the understanding of some of the later parts of this dissertation, it is appropriate 
to provide a brief background on this polymer. For an in depth understanding the reader 
is referred a comprehensive review by Schild.
[43]
 One of the earliest studies on the 
solution properties of pNIPAm was carried out by Heskins et al.,
[44]
 where they observed 
that the phase transition of pNIPAm is endothermic and entropy driven. Due to this 
striking thermal behavior in aqueous media, pNIPAm has been widely used to make 
responsive hydrogels. As with most olefin-based monomers, pNIPAm has been 
synthesized by a variety of techniques: redox initiation, free radical initiation, ionic 
initiation and also using radiation.
[43]
 Various functional groups have also been added to 
the polymer via co-polymerization and post-polymerization modification, thereby making 
multiresponsive and multifunctional polymers. Another polymer with similar behaviors is 
poly(N-isopropylmethacrylamide) (pNIPMAm). Further discussion of this polymer will 
follow in this chapter. 
The behavior of any polymer in a solvent is related to the balance between 
solvent-solvent, solvent-polymer, and polymer-polymer interactions. For stimuli-
sensitive polymers, the polymer solvation can be “switched” by enforcing one of these 
interactions or by weakening another. For the case of pNIPAm in water, the polymer 
hydrogen bonds to water via the amide side chains. However, the isopropyl group on the 
sidechain induces hydrophobic structuring of the water. This structured water leads to 





the conditions where pNIPAm has a random coil structure, the solvent-polymer 
interactions are stronger than the polymer-polymer interactions. At higher temperatures 
the hydrogen bonds with the water molecules break and there is an entropically-favored 
release of bound and structured water, leading to the formation of a globular polymer 
conformation. In this case the polymer-polymer hydrophobic interactions become 
stronger than the polymer-solvent interactions, and the polymer phase separates. Figure 
1.1 illustrates this concept schematically. The temperature at which this phase separation 
occurs is called the lower critical solution temperature (LCST). It is this behavior that 
makes pNIPAm very attractive candidates for the fabrication of stimuli-responsive 
hydrogels. It is worthwhile noting, however, that one must consider more than simply 
hydrophilic and hydrophobic sidechain contributions to polymer solvation when 
describing LCST behavior. For example, the polymer formed from N-
isopropylmethacrylamide,
[45-50]
 which differs from NIPAm by only a single methyl 
group, has a higher LCST in water, which suggests that it is more hydrophilic despite a 
greater organic content. Apparently, this “increased hydrophilicity” does not arise from 
an increase in polymer polarity, but instead comes from a decrease in chain flexibility. 
This changes the entropic contribution to the free energy of mixing, and thus increases 














Figure 1.1. Structuring of water around pNIPAm hydrogel networks as the temperature 





The LCST behavior of pNIPAm has been studied by a variety of techniques 
including UV-VIS, differential scanning calorimetry, light scattering, viscometry and 
fluorescence spectroscopy.
[51-59]
 Wu et al. have extensively studied the phase transition of 
pNIPAm, where they observed that the transition is not first order i.e. the polymer does 
not directly go from a random coil state to a globular state, but there are other 
intermediate thermodynamically stable conformations.
[54, 56, 60]
 There are other classes of 
thermoresponsive polymers that show an upper critical solution temperature (UCST). In 
~ 31 °C 
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this case the polymer is phase separated at low temperatures due to inter- or 
intramolecular interactions, while at high temperatures these interactions break and 
dissolve or swell the polymer. Most often these interactions are hydrogen bonding or 
electrostatic. In one example Laschewsky and co-workers have synthesized a block co-
polymer of pNIPAm and 3-[N-(3-methacrylamidopropyl)N,N-dimethyl]ammoniopropane 
sulfonate (SPP), which exhibits both LCST and UCST behavior.
[61]
 The pNIPAm 
segment provides temperature sensitivity via the mechanism described above. On the 
other hand, SPP is a polyampholytic polymer, which at low temperatures displays strong 
electrostatic interactions between the oppositely charged regions of the polymers, while 
these interactions are broken at high temperatures. 
 
1.1.4 Swelling Properties of Hydrogels 
The nature of hydrogels is dependent on the type of the monomers used to 
synthesize them. In case of hydrogels synthesized from pNIPAm, the thermoresponsivity 
of the parent polymer is inherited by gels made from it. These hydrogels exhibit volume 
phase transition temperature (VPTT)
[62]
 at around the LCST of pNIPAm. At temperatures 
higher than VPTT the hydrogel goes from a swollen (hydrophilic) state to a deswollen 
(relatively hydrophobic) state. The VPTT of the gels is dependent on several factors 
including cross-link density, hydrophobic-hydrophilic balance, ionic strength, and solvent 
composition. Correspondingly, hydrogels fabricated from titratable ionic monomers show 
pH dependent swelling. The most common ionic monomers used are acrylic acid and 
methacrylic acid. When the pH > pKa of the acid comonomer, the gel swells due to 
Coulombic repulsion between the charged monomer units and more favorable solvation 
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of the deprotonated monomer by the solvent. The equilibrium gel swelling volume is a 
balance between the osmotic pressure of the polymer network, which is governed by 
polymer-solvent interactions, and the elasticity of the network.
[8]
   
In classic and groundbreaking work, the group of the late Toyoichi Tanaka 
showed that ionic thermoresponsive gels, when heated, display a discontinuous transition, 
while nonionic gels undergo a continuous transition. They have also shown that the 
shrinking rate of the gel is inversely proportional to the square of the smallest dimension 
of the gel.
[6, 37, 63-65]
 Taking advantage of the diffusion length scale, Yan and Hoffman 
have shown that polymerizing pNIPAm gels at temperatures higher than the LCST of the 
polymer results in gels having large pore size, which in turn have faster swelling rates.
[66]
  
This swelling behavior of hydrogels has made them useful in some interesting 
applications. Thermosensitive pNIPAm gels have been used to control the activity of 
enzymes. Park and Hoffman demonstrated that by immobilizing an enzyme in the gel, the 
diffusion of the substrate to the enzyme could be controlled by changing the pore size of 
the gel, which in turn depends on the temperature of the system. In this way they were 
able to switch the enzyme on or off by controlling the temperature.
[67]
 Kim and Healy 
have synthesized pNIPAm gels with peptide cross-links. These gels can be used as an 
extracellular matrix mimic, where the peptide can be cleaved by a metalloproteinase, 




1.1.5 Microgels and Nanogels 
Colloidally stable particles made from hydrogels, also referred to as micro- or 
nanogels, have similar properties as their macrogel counterparts i.e. a pNIPAm microgel, 
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like the bulk gel, will also undergo a VPTT near the LCST of the parent polymer.
[25, 69]
 In 
addition to these properties, microgels have other characteristics of colloidal dispersions 
such as zeta potentials,
[25, 70, 71]




Some very important studies have focused on the differences between macro- and 
microgels with respect to their phase behavior. For example, Wu et al. have shown that 
the VPTT of the microgels is slightly higher than the LCST of pNIPAm, and also that the 
transition region is less sharp than that of bulk gels.
[76]
 The reason for this continuous 
transition is due to a greater heterogeneity in the subchain lengths of the microgels as 
compared to traditionally prepared macrogels. When the microgels are subjected to T > 
VPTT, the regions of the particle with longer subchain lengths collapse at a lower 
temperature than the regions with shorter subchains. Thus one can think of the observed 
phase transition for a microgel as being the summation of the phase transitions of the 
different sub-networks in the particle. The Lyon group has also observed this behavior in 




Understanding the structure of hydrogel nanoparticles is important from the 
viewpoint of explaining their detailed phase transition behavior, mass transport through 
the network, and colloidal stability. Light scattering is one of the most common 
techniques used for structural analysis of hydrogel nanoparticles. Both dynamic and static 
light scattering have been used extensively and remain the standard techniques for 
particle characterization.
[25, 76, 78-80]
  However, other techniques have allowed for even 
greater insight into the structure of microgels. Guillermo et al. used NMR to determine 
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the cross-linker distribution in pNIPAm microgel particles and confirmed that these 
particles have a heterogeneous structure, wherein the periphery of the microgel is more 
loosely cross-linked than the interior.
[81]
 Similar studies were carried out by Saunders, 
where Small Angle Neutron Scattering (SANS) was used to investigate the structural 
details of pNIPAm microgels synthesized by surfactant free polymerization.
[82]
 This 
study again revealed that the microgels prepared by precipitation polymerization have a 
heterogeneous structure, where in that case it was determined that a thin layer of loosely 
cross-linked chains was present at the particle periphery. Woodward et al. used 
Differential Scanning Calorimetry (DSC) to determine the influence of cross-linking 
density on the phase transition of the particles. They observed an overall decrease in 
phase transition enthalpy with increase in cross-linker density.
[83]
 In addition to DSC they 
also used pulsed gradient spin echo (PGSE) NMR to study the mobility of the solvent in 
the particle as a function of cross-linker density and observed that the diffusion of solvent 
is reduced with the increase in the cross-linker density, hence making the particles more 
rigid at high cross-linker density. Senff et al. have used rheometry to understand the 
phase behavior of microgels and to determine the effective “softness” of microgel 
particles.
[73, 84, 85]
 This group has also carried out studies aimed at determining the internal 
structure of microgels.
[86, 87]
 Again, it was determined that the cross-link density is 
highest at the center of the particle and decreases gradually to the surface. They also 
found that the internal structure of the microgels depends on the manner in which they 
are synthesized. A semibatch reaction (reactants are added gradually over a certain time 
period) gives more homogeneous morphology than a simple batch reaction (all the 
reactants are added at the start). This effect is attributed to the faster reactivity of the 
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cross-linker, which gets incorporated at a faster rate during the early stages of a batch 
reaction. Similar behavior has also been reported by Pelton.
[69, 88]
 
Chemical functionalization of microgels not only facilitates control over the 
volume phase transition but also allows post-polymerization modifications and provides 
handles to trigger response to external stimuli like pH, ionic strength or light. However to 
achieve efficient design of functional microgels based on chemical modification, it is 
important to understand how the functional groups are distributed in the polymer 
network. A recent report by Hoare and Pelton gives an insight into this aspect. The 
researchers describe two different methods of obtaining controllable distribution of the 
functional groups in the system.
[89]
 As the first method, acrylic acid groups were 
incorporated in acrylamide/NIPAm microgels by hydrolyzing the acrylamide blocks. The 
second method involved direct copolymerization of methacrylic acid (MAA) with 
NIPAm. The distribution of the acid functional groups obtained by the two methods had 
different topochemical distributions. Another factor that influenced the distribution is the 
temperature of AM hydrolysis i.e. above or below the LCST of the microgel. Based on 
potentiometric and conductometric titrations as well as electrophoretic mobility 
evaluations of the microgels, it was found that at a temperature below the LCST, most of 
the carboxyl groups were located throughout the microgel, whereas at a temperature 
above the LCST, a high percentage of carboxyl groups was found to be located at or near 
the surface of the microgels. In case of pMAA-co-pNIPAm microgels, there exists a 
core-shell kind of a structure with MAA mostly forming the shell. This difference in the 
distribution of the carboxyl groups in the microgels produced by the two different 
comonomers is because of the difference in the polymerization kinetics due to different 
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reactivity ratio of the monomers. The copolymer of acrylamide and NIPAm is expected 
to have random incorporation of the monomers resulting in acrylamide and hence 
carboxyl groups on hydrolysis, throughout the bulk of the microgel. On the other hand, 
the reactivity ratios of MAA and NIPAm suggest that there is greater affinity for the 
homopolymerization of NIPAm, which is followed by MAA monomer polymerization 
resulting in the core-shell- like structure. 
 
1.2. Synthesis of Hydrogel Nanoparticles 
 Hydrogel nanoparticles have been synthesized by numerous approaches. In this 
section we will discuss some of the commonly used methods, where the synthetic 
technique being employed is typically dictated by the desired application or the type of 
study to be carried out. The synthetic method is of particular importance when one 
considers bioconjugation of the resultant material, as the location, density, and identity of 
the chemoligation sites on the microgel will dictate the function and utility of the 
bioconjugate. 
 
1.2.1. Emulsion and Precipitation Polymerization 
Surfactant Free Emulsion Polymerization (SFEP), or precipitation polymerization, 
is the most common technique to synthesize thermosensitive hydrogel particles. Although 
pNIPAm microgel synthesis by this method was not reported in the literature until 1986, 
the technique was apparently first utilized by Philip Chibante in 1978.
[69, 90]
 If carried out 
carefully, this method can afford particles with very narrow size distribution. In this 
method all the monomers, NIPAm and the cross-linker (typically N,N’-
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methylenebisacrylamide (BIS)), are dissolved in water. The solution is purged with N2 
and heated to a temperature far above the pNIPAm LCST (usually ~70 °C), followed by 
addition of a thermally decomposed free-radical initiator such as ammonium persulfate 
(APS) or potassium persulfate (KPS). 
Microgels synthesized by this method are formed by homogenous nucleation. 
There are two reasons for carrying out the polymerization at high temperature. One 
relates to the formation of sulfate radicals, which initiate the polymerization. Secondly, 
after initiation the NIPAm monomer is attacked by the sulfate radical, followed by radical 
propagation and chain growth. Once the chain reaches a critical length, it collapses upon 
itself producing precursor particles. The chain collapses because the polymerization 
temperature is higher than the LCST of the polymer, hence the name precipitation 
polymerization. The precursor particles grow by aggregation with the other precursor 
particles, being captured by existing particles, by capturing growing oligoradicals, and by 
monomer addition. The charge imparted by the initiator stabilizes the microgels once 
they have reached a critical size. Figure 1.2 shows the proposed mode of particle growth 
that occurs during precipitation polymerization. This method is extremely versatile from 
the standpoint of particle size control. For example, to synthesize smaller microgels, the 
precursor particles must be stabilized earlier in the reaction. Since there is not enough 
charge available from initiator fragments to stabilize small precursor particles, an ionic 
surfactant can be added to impart colloidal stability earlier in the reaction. Similarly, 
larger particles can be obtained by decreasing the surfactant concentration. Precipitation 
polymerization can also be used to incorporate comonomers in the microgel. The Lyon 





 Our group has also copolymerized a hydrophobic 
comonomer N-tert-butylacrylamide (TBA) in to pH/temperature responsive microgels; 
these particles exhibit phase transitions at lower temperatures due to the increase in 
hydrophobicity of the gel while retaining a pH tunable VPTT.
[95]
 Similarly, other 












Figure 1.2. Free-radical precipitation polymerization- a growing oligoradical chain 
reaches a critical length and collapses on itself, creating a precursor particle, to which 








The presence of a cross-linker is critical in preventing the dissolution of the 
polymer particle as it is cooled below the LCST. However, Gao and Friskin have reported 
that it is possible to make pNIPAm microgels by precipitation polymerization without 
using a cross-linker.
[96, 97]
 They attributed this effect to “self cross-linking” of pNIPAm 
chains by a chain transfer reaction occurring at either or both of two possible sites: the 
hydrogen atom attached to the tert-C on the pendant isopropyl group and the hydrogen 
atom on the tert-C of the main chain backbone. These results indicate that in precipitation 
polymerization the cross-link density might be higher than one expects on the basis of the 
cross-linker concentration used in the reaction. 
 Precipitation polymerization has a few drawbacks. First, the method is useful only 
for materials that are stable at high temperatures and hence cannot be used to incorporate 
biological macromolecules. Also the method is best for materials that are hydrophobic so 
that they can attach to the collapsed precursor particle easily. Hence, if a hydrophilic 
comonomer is to be copolymerized, only a certain wt % can be incorporated. Beyond that 
wt % the growing oligomer will be too hydrophilic to undergo efficient chain collapse, 
thereby resulting in polydisperse microgel dispersions, or the complete lack of particle 
formation. To overcome these hurdles many researchers have used inverse 
microemulsion polymerization. In this method an aqueous solution of all the monomers is 
added to an appropriate amount of oil and surfactant and is stirred to form 
thermodynamically stable microemulsions. Polymerization can be initiated by having the 
initiator in the aqueous or in the oil phase. This method has been used to synthesize 
hydrogel particles with high wt % of ionic monomers; Neyret and Vincent used 
microemulsion polymerization to prepare zwitterionic pNIPAm microgels.
[98]
 In this case 
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they used a UV-activated photoinitiator dissolved in the organic phase. McAllister et al. 
used the same technique to synthesize a highly cationically charged hydrogel. These 
particles were able to bind to DNA and can potentially be used in gene delivery.
[99]
 One 
other method for preparing microgels, which is similar to microemulsion polymerization, 
utilizes lipids to form liposomes inside which the particle is formed. Kazakov et al. have 





1.2.2. Core/Shell Structured Materials   
 Core/shell hydrogel particles can broadly be divided in two classes: one where the 
core is made from non-hydrogel material and the shell is made from hydrogel and the 
second being where both the core and the shell are made of a hydrogel-like material. In 
the first class of materials the core is usually made of solid material such as polystyrene, 
silica or gold nanoparticles. Dingenouts et al. synthesized a polystyrene core with small 
amount of NIPAm as a co-monomer by SFEP.
[101]
 The polystyrene-co-pNIPAm particles 
were stabilized by the sulfate groups from the initiator. These cores were then used as 
seeds for polymerizing a cross-linked shell of pNIPAm. For the shell synthesis the 
reaction was carried out at 80 °C, which provided a core particle with a deswollen 
pNIPAm-rich periphery, onto which pNIPAm polymerizing in solution aggregated by a 
precipitation polymerization mechanism. Xiao et al. synthesized similar particles where 






 In another example, Zha et al. have used silica particles prepared by the Stöber 
method
[103]
 as a core material.
[104]
 Vinyl groups were introduced to the surface of the 
particles via a silane coupling reaction. These particles were then used as seeds for 
precipitation polymerization of pNIPAm, which resulted in the formation of silica-
core/pNIPAm-shell particles. This approach further allowed for the synthesis of hollow 
pNIPAm capsules by dissolution of the silica with HF. Similarly, Kim and Lee have 
synthesized gold-core/pNIPAm-shell particles by SFEP. The size of the gold 
nanoparticles was ~60 nm, which were stabilized by citrate. These gold nanoparticles 
were then reacted with oleic acid, which helps in attaching the pNIPAm hydrogel shell to 
the gold core during SFEP.
[105]
 
The second type of core/shell materials is the one that has hydrogel in both the 
core and the shell. Our group first reported the synthesis of this type of hydrogel particles 
by two-stage precipitation polymerization.
[22]
 In this method a polymer shell of the same 
or different structure or functionality of the core, is added onto preformed core particles 
thereby allowing control over the radial distribution of the functional groups in the 
particle. In a typical synthesis, preformed pNIPAm or pNIPMAm core particles are 
heated to ~70 °C, followed by addition and initiation of the shell monomer solution. The 
reaction is carried out for ~4 h and then the mixture is cooled and filtered. This method 
gives core/shell particles with no increase in polydispersity, as all oligomers formed in 
solution precipitate on pre-formed core particles. To prevent heteronucleation there are 
several important parameters that should be controlled, including the concentration of the 
core, initiator, surfactant and the shell monomer. The mechanism by which this reaction 
takes place is somewhat similar to that for the core microgels. Since the reaction 
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temperature is well above the VPTT of the core particles, the particles are in a collapsed 
state. The collapsed particles are hydrophobic and hence they tend to capture the growing 
oligomers, which results in the formation of the shell. 
Core/shell particles prepared in this fashion can exhibit very interesting 
properties.
[21,45,46,77,106-110]
 Since the shell can be synthesized using different comonomers 
than the core, the particles can show multiple phase transition behavior with 
temperature.
[22, 45, 46]
 Furthermore, depending upon the cross-linker density of the shell, 
compression or “shrink-wrapping” of the core can be observed due to a cross-link 
gradient in the shell.
[106, 107, 109, 110]
 The Lyon group has also used this synthetic method to 
make hollow hydrogel capsules.
[111]
 To accomplish this, the core is fabricated with a 
degradable cross-linker and the shell with a non-degradable one. The degradable cross-
linker that we have used contains a vicinal diol, which can be degraded by stoichiometric 
addition of periodate. After core degradation, the particles were cleaned extensively by 
centrifugation, after which DLS and fluorescence were used to confirm the hollow 
structure. 
Berndt and Richtering have also synthesized core/shell particles having two 
different polymers in the core and the shell.
[45]
 In their demonstration, the core was made 
of pNIPAm and the shell consisted of poly(N-isopropylmethacrylamide) (pNIPMAm), 
which has a LCST of 45 °C. They studied the thermoresponsivity of these particles and 
found, in a similar fashion to previous work from our group, that the particles had two 
transitions corresponding to the LCSTs of the two polymers. In a recent study the 
researchers investigated the effect of shell thickness and cross-linking density on the 
structure of the doubly-temperature sensitive core-shell microgel networks using Small 
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Angle Neutron Scattering (SANS) techniques.
[112, 113]
 It was observed that variation of 
cross-linking density in the shell mainly affects the dimensions of the shell without 
affecting the core. However, increase in the shell to core mass ratio, leads to increased 
expansion of the core with a broader core-shell interface between the LCSTs, thus 
indicating the elastic force exerted on the core by expanding shell. Studies at a 
temperature below the LCST of the core suggested that the core of the core-shell particle 
was unable to swell to the same extent as a core in the absence of a shell, thus indicating 
that the expanded shell prohibits the swelling of the core. In another report, the same 
research group observed that an increased shell thickness shifts the core transition 
towards higher temperatures while the collapse of the core can shift the transition of a 
thin shell to lower temperatures.
[114]
 An additional thermal transition is also observed in 
these core-shell microgels, which was attributed to the formation of additional hydrogen 
bonds near the core-shell interface resulting from the overcompensation of the 
thermodynamic forces during the core transitions by the elastic forces in the shell. 
 
1.2.3 Post Polymerization Modification of Hydrogels 
 For certain applications not all of the desired hydrogel functionalities can be 
added during the polymerization step. There are several reasons for this: the desired 
functionalities may not be stable during the polymerization step or the molecules are 
simply not polymerizable. This is especially true for most biomolecular structures from 
which hybrid gels would be prepared. To allow further functionalization of hydrogels, 
most often a small amount of comonomer with acidic or basic functionality is 
copolymerized during the polymerization step. These functional groups are then used for 
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attachment of molecules that could not be directly incorporated by polymerization. This 
particular class of syntheses encompasses a large variety of particles, of which only a few 
will be mentioned in this chapter.  
 The group of Haruma Kawaguchi has used post polymerization modifications 
extensively for making particles with variety of functions.
[115]
 For example, to synthesize 
a tetra-functional particle, they first synthesized standard microgels using acrylamide, 
BIS, methacrylic acid and p-nitrophenyl acrylate as the co-monomers. The thus 
introduced ester side chain can be hydrolyzed to give acidic particles, or after hydrolysis 
can be reacted with ethylene diamine to give amphoteric particles. The acid groups were 
also coupled with a long chain alkyl amine to form hydrophobic particles. Finally the 
acid groups were coupled to an IgG to form bio-functionalized microgels. This particular 
report illustrates the tremendous versatility in microgel structure and function that is 
offered by post polymerization modification. 
 Another interesting system involved the synthesis of pNIPAm chains bearing 
terminal carboxyl groups, which were then grafted to microgels. The carboxy termini 
were then used to attach the enzyme trypsin, resulting into a particle having two different 
kinds of pNIPAm chains on the surface: one with trypsin and the other without it. 
Surprisingly, it was found that the two chains had different transition temperatures. The 
free chains collapsed at a lower temperature than the trypsin conjugated chains, thereby 
exposing the enzyme for substrate binding. Hence by this simple construct they were able 
to control the enzyme activity by controlling the temperature.
[116]
  
 In a report by Delair, et al, the immobilization of DNA on microgels by post 
polymerization modification was described. Microgels composed of pNIPAm with an 
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amine comonomer were synthesized. Single stranded DNA with an amine group at the 5’ 
end was reacted with 1,4-phenylene diisocyanate in 1:2 ratio so that one of the 
isocyanates was coupled to the DNA, while the other one remained free. After 
purification, the DNA was coupled to the pNIPAm microgels by reacting the free 
isocyanate with the amines on the surface of the particles. The DNA particles were then 




Post polymerization modification can not only be used for coupling biomolecules 
but also for grafting synthetic polymer chains. Hu et al. synthesized pNIPAm microgels 
and grafted pNIPAm chains on these particles by RAFT.
[118]
 They then used these 
particles to study thermal behavior of the grafted polymer. In another example Hu and 
Wu grafted poly(ethylene oxide) (PEO) chains on the microgel particles. The hydrophilic 
PEO chains were observed to stretch from the particle surface as the particles size 




1.3. Bioconjugated Hydrogel Particles in Nanotechnology 
 The synthetic methods described in the previous sections have enabled the field to 
advance towards the application of hydrogel nano- and microparticles in more complex 
biotech and nanotech applications. In this section, we will describe some of these 
applications, highlighting systems where the ability to create synthetically and 





1.3.1. Drug/Gene Delivery  
 Recently, significant efforts have been put into devising colloidal drug carriers. It 
has been hypothesized that an actively targeted particulate drug carrier will increase the 
therapeutic efficacy of a drug by delivering that drug to the diseased site, while also 
reducing systemic side-effects of the drug. An ideal drug carrier should be able to target 
and deliver only to the diseased sites, it should not induce immune response, and it 
should be degradable and produce non-toxic degradation products.
[120]
  
 The particulate carriers that have been most widely studied are liposomes and 
polymer nanoparticles. Liposomal drug carriers have been studied extensively, with a few 
liposomal formulations currently being available in the market, while many others are in 
the development “pipe-line”. One important drawback of liposomes is payload leakage. 
Since the boundary of the liposomes is a simple lipid bilayer, performance can be 
hampered by passive diffusion of drugs across that boundary.
[121]
 Among polymer 
particles, the most widely studied are poly(lactic acid-co-glycolic acid) (PLGA) 
particles.
[122]
 The popularity of this material largely stems from its degradation into non-
toxic byproducts, which can be removed from the body via the renal system. However, 
this construct suffers from numerous drawbacks, as it is a very hydrophobic, 
immunogenic polymer with acidic degradation products. The increase in acidity 
associated with polymer degradation can induce non-specific inflammatory responses, 
which can be very detrimental in targeted delivery applications. Non-viral gene delivery 
systems have been proposed as a safer alternative to viral vectors, since they will induce 
host immune response to a lesser extent than viral vectors. Several cationic polymers 
such as polyethyleneimine, polyamidoamine and polylysine, have been used for non-viral 
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gene delivery, but they all lack the biocompatibility needed for in vivo use.
[123]
 
Conversely, hydrogel nanoparticles represent a potentially useful class of materials in 
drug/gene carrier systems, but have been studied much less extensively. Here we report a 
few examples of recent efforts involving nanoparticulate hydrogel delivery vehicles. 
 In an effort to employ naturally-occurring polymers as delivery vehicles, Wang 
and Wu used agarose gel particles for protein delivery.
[124]
 A model protein ovalbumin 
was encapsulated in ~500-nm diameter, spherical agarose gel particles. Following protein 
loading, it was demonstrated that the particles released ovalbumin in a temperature 
dependent fashion, where the rate of protein release was higher at elevated temperatures. 
This was due to the larger swelling volume of agarose at higher temperature, which 
facilitates mass transport. Another example of protein delivery was reported by Li et 
al.,
[125]
 who demonstrated the use of poly(vinyl alcohol) hydrogel nanoparticles for this 
application. These particles were prepared by an emulsion technique without 
incorporating any cross-linker. The model protein bovine serum albumin (BSA) was 
incorporated during the particle formation. As with the previous example, the rate of 
release of BSA increased with temperature. The authors attribute this behavior to the 
decrease in the number of cross-links at higher temperature in the polymer network, 
thereby making the gel network more “open” for the transport of BSA. Using this 
methodology, the authors were able to demonstrate release of BSA over ~30 h. 
Biodegradable hydrogel nanoparticles have been prepared by Kim et al. using glycidyl 
methacrylate dextran as the major co-monomer and dimethacrylate poly(ethylene glycol) 
as a covalent cross-linker.
[126]
 In this case, the particles were prepared by free radical 
polymerization and a hydrophobic drug, clonazepam, was then loaded in the particles. It 
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was found that the release rate was dependent on the pH as well as the concentration of 
the enzyme dextranase, which degraded the dextran and eroded the particles. Na and Bae 
have used self assembled hydrogel particles of pullulan acetate and sulfonamide 
conjugates to study the release of the drug adriamycin.
[127]
 In this case the pullulans had 
pH responsive polymer incorporated in the structure, which caused the particles to shrink 
and aggregate at pH < 7. The shrinking of the particles in turn caused the expulsion of the 
drug into the surrounding medium. 
Peppas and co-workers have used hydrogels as a delivery vehicle to carry insulin. 
[128]
 Poly(methacrylic acid) and poly(ethylene glycol) were used to synthesize the 
hydrogels by UV-initiated free radical polymerization.  Insulin was then conjugated to 
the protein transferrin, and this complex was loaded into the hydrogels.  The insulin-
transferrin conjugate is used as it has been shown to cross the intestinal epithelium.  By 
loading the insulin-transferrin complex into the hydrogels, Peppas and co-workers feel 
this can be used as an oral delivery system for insulin, as it provided increased stability 
against proteolytic degradation.  Insulin was conjugated to transferrin by reacting it with 
dimethylmaleic anhydride (DMMA).  The transferrin was conjugated with succinimidyl 
3-(2-pyridyldithio)propionate (SDSP).  The DMMA and SDSP were then reacted to form 
the insulin-transferrin conjugate, which were then loaded into the hydrogels.  A 22-fold 
increase in transport of insulin across Caco-2 cell monolayers was seen with conjugate-
loaded hydrogels versus insulin alone.   
 An interesting example of controlled release of a drug from a microgel comes 
from the group of David Needham.
[129]
 They used ~6.5 µm diameter methacrylic acid 
microgels as a matrix for drug encapsulation and release. While these particles are by no 
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means in the nanoscale-range, they illustrate an interesting concept that could be 
extended to the nanoscale. Under conditions where the particles are deprotonated and 
hence swollen due to Coulombic repulsion between the negatively charged regions, the 
particles could be loaded with the anti-cancer drug doxorubicin. Upon reducing the pH of 
the medium below the acid pKa, the particles condensed. To prevent leakage of the drug 
from the polymer, the particles were then coated with a lipid bilayer. These lipid coated 
particles were then suspended in a medium of pH > pKa. Surprisingly, no gel swelling 
was observed and hence no drug was observed to leak from the construct. In order to 
release the drug, a series of voltage pulses were applied to electromechanically disrupt 
the bilayer and cause the swelling of the particle. Thus, the authors illustrated that the 
drug could be protected and then be released on demand using a subtle stimulus. A 
similar example was published by Jeffrey Moore’s lab. Again, in this example the 
polymer constructs are not at nanoscale level but nonetheless provide an interesting 
concept.
[130]
 A pH sensitive gel was photopolymerized in a cylindrical shape. The gel was 
fabricated from 2-hydroxyethyl methacrylate, acrylic acid and ethyleneglycol 
dimethacrylate. Palmitoyl chloride was then covalently bound to the surface of the gel. 
This modification of the gel created an ion barrier that enabled the pH sensitive gel to 
remain in a condensed state even in high pH media. This barrier was disrupted by a 
surfactant, which caused the gel to swell. The ability of the fatty acid layer to maintain a 
sharp chemical potential gradient is analogous to the function of a cell membrane and 




 While the previous examples were simple demonstrations of ex vivo controlled 
release from hydrogel particles, others have applied nanoparticulate hydrogels to in vivo 
delivery. For example, Hsiue et al. have used pNIPAm nanoparticles for ocular 
delivery.
[131]
 Two formulations were used, where one was composed of a solution of 
linear pNIPAm, while the other was mixture of linear pNIPAm and pNIPAm particles. 
The drug release and cytotoxicity studies were carried out on rabbits. The drug 
epinephrine, which reduces intraocular pressure, was then delivered from each of the two 
formulations. It was observed that the intraocular pressure was decreased for ~24 h when 
the linear pNIPAm system was used, while the mixed system extended the therapeutic 
effect to ~32 h. Systems such as these are therefore potentially interesting for the clinical 
treatment of glaucoma. 
 As mentioned above, an ideal drug carrier should not induce an immune response 
in the host. This is commonly achieved by making the surface of the particle hydrophilic, 
which can prevent opsonization (i.e. adhesion enhanced phagocytosis) by 
macrophages.
[132]
 For example, Gaur et al. synthesized cross-linked polyvinylpyrrolidine 
hydrogel nanoparticles (~100 nm diameter).
[133]
 The surface of these particles was then 
made hydrophilic by attaching poloxamers and poloxamines, which are examples of 
polyethylene glycol/polypropylene glycol block copolymers. In vivo studies in mice 
indicated that less than 1% of the dose was retained by the macrophages in the liver, and 
even after 8 h of injection ~5-10% of these particles were still circulating in the 
vasculature. This enhanced circulation time, and the lack of liver accumulation, could 
enable the use of such particles in drug delivery. They also reported that increase in size 
and hydrophobicity increased their uptake by reticulo-endothelial system, suggesting that 
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both factors may play a role in the ability of the body’s defense mechanisms to recognize 
the particles as foreign invaders. 
 Targeting is an important property for a drug carrier, as one can potentially 
enhance the uptake and retention of the nano-carrier at the site of disease via active 
targeting. The Lyon group has synthesized a folic acid labeled pNIPAm core/shell 
microgel that can target cancer cells.
[134]
 Folic acid is a well-known ligand for targeting 
cancer cells because most tumors overexpress folate receptors. In this demonstration, 
pNIPAm core/shell hydrogel particles were synthesized, where the pNIPAm core was 
fluorescently labeled and the pNIPAm shell contained a small amount of a co-monomer 
containing a primary amine. We then covalently coupled folic acid to the amine-
containing hydrogel shell in order to surface localize the targeting ligand. When these 
particles were incubated with cancer cells that were overexpressing the folate receptor, 
the hydrogel nanoparticles were taken up by receptor mediated endocytosis. It was also 
observed that the particles exhibited thermal cytotoxicity above the phase transition 
temperature. The exact reason for this effect is not known but is suspected to be 
intracellular aggregation and protein adsorption on deswollen, hydrophobic pNIPAm 
particles. Since these particles apparently retain their thermoresponsivity in the cytosol, it 
was hypothesized that they could enable thermally-triggered delivery of 
chemotherapeutic payloads, thereby enabling both active targeting and triggered delivery 
in one vehicle. 
 In another example of active targeting, Choi et al. used pNIPAm microgels for 
targeting liver cells.
[135]
 They used pNIPAm-co-acrylic acid microgels that were tagged 
with fluorescein, while the targeting moiety in this case was galactose, which is a ligand 
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for asialoglycoproteins. It was observed that galactosylated microgels were internalized 
in the cells via this ligand-receptor interaction. Furthermore, since these particles are 
thermoresponsive, they studied temperature dependent uptake of these particles. The 
uptake efficiency increased with the increase in temperature, which they suggested was 
due to enhanced uptake efficiency for smaller particles, although the increase in particle 
hydrophobicity could also enhance uptake. The Wooley group has investigated SCKs 
with targeting ligands like folic acid, integrins and peptides.
[136-138]
 They have also 
demonstrated that nanoparticles coupled with a short peptide belonging to protein 
transduction domain of HIV exhibited targeting ability to CHO and HeLa cell lines. 
Kumacheva and co-workers describe another hydrogel design to be used for 
cancer targeting.
[139]
  In this work, pNIPAm-co-AAc hydrogel particles averaging 150 nm 
in diameter were synthesized.  Hydrogel particles were conjugated with transferrin by 
carbodiimide coupling. The transferrin was used to target the particles to HeLa cells, as 
transferrin receptors are present on the surface of HeLa cells, thereby enabling receptor-
mediated endocytosis.  These hydrogels were loaded with Rhodamine 6G (R6G) and later 
with doxorubicin to study uptake and delivery.  The transferring-conjugated particles 
delivered 100 times more R6G to cells than bare microgels, and cell mortality was greatly 
enhanced over bare, doxorubicin-loaded microgels (72.6% ± 5.0% vs. 33.8% ± 2.8%). 
The polysaccharide chitosan and its derivatives, on account of their 
biocompatibility, biodegradability, nontoxicity and mucoadhesive property, are very 
attractive precursors for synthesizing delivery vehicles. Kumacheva and coworkers 
recently developed chitosan-based microgels which release the cancer drug methotrexate 
disodium, MTX triggered by a pH change.
[140]
 The microgel synthesis strategy was 
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designed to yield a particle of well-defined size, with a surface which could be 
bioconjugated with cell receptor-specific ligands and ability to deliver the drug in 
response to a pH stimulus. The synthesis involved grafting of (2-hydroxyl) propyl-3-
trimethylammonium to the chitosan to form the derivative N-[(2-hydroxyl-3-
trimethylammonium) propyl]chitosan chloride (HTCC). The quaternary ammonium side 
chains were cross-linked by ionic association to negatively charged tripropylphosphate 
(TPP) to form microgels. The microgels were stable at physiological pH and showed 
swelling in the range of 3< pH <6 due to increased electrostatic repulsion in the polymer 
network arising mostly from the high degree of protonation of the primary and secondary 
amino groups of HTCC. The protonation of TPP at pH 2.5 (pKa values of TPP = 2.3 and 
6.3), resulted in the decrease of the degree of cross-linking resulting in tremendous 
increase in the microgel size (from diameter 180nm to ~1100nm). Since the microgel was 
positively charged at pH 7.4 they were able to easily load a negatively charged drug 
MTX through electrostatic interactions. The loaded drug was released (pH 7.4) about 
66% in a single day, while 30% remained trapped beyond 5 days. At pH 5.0, about 93% 
of the loaded drug was released after 1 day and about 95% after 3 days. Receptor-
mediated intracellular uptake, which triggers drug-releasing cellular pH changes, was 
facilitated by conjugation of transferrin to the surface of the microgels using 
carbodiimide coupling chemistry. The MTX-loaded, transferrin-conjugated microgels 
were conjugated with negatively charged luminescent CdSe/ZnS quantum dots to allow 
imaging of the cellular entry of the particles. The transferrin-conjugated MTX-loaded 
microgels showed 4.8 and 2.8-fold increase in cell mortality when compared to pure and 
non-bioconjugated MTX-loaded microgels respectively.  
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 Synthetic/viral composite systems have also been explored. For example, Jana et 
al. prepared polyvinylpyrrolidone nanoparticles and encapsulated them in a reconstituted 
Sendai viral envelope containing only the fusion proteins.
[141]
 These particles were 
incubated with human hepatoblastoma cell lines, which resulted in internalization of the 
polymer particles, as confirmed by fluorescence. Na et al. have used self assembled 
polysaccharide (curdlan) particles for targeting.
[142]
 Curdlan was hydrophobically 
modified with a carboxylated sulfonylurea derivative. The targeting ligand was 
lactobionic acid, which targets HepG2 cells. As expected, the degree of non-targeted 
uptake was significantly diminished relative to that for particles targeted to HepG2 cells. 
 Many groups have used cationic polymers such as chitosan for gene delivery. 
Chitosan is a natural cationic polysaccharide consisting of D-glucosamine and N-acetyl-
D-glucosamine. This polymer has been shown to be biocompatible, non-immunogenic 
and degradable, thereby making it potentially suitable as a delivery vehicle. In the 
presence of polyanions, chitosan can form hydrogel nanoparticles by complex 
coacervation. For example, chitosan-DNA nanoparticles have been widely studied for 
their application in gene delivery. Mao et al. have synthesized chitosan-DNA 
nanoparticles and studied the transfection efficiency.
[123]
 Targeting agents, like 
transferrin, have also been conjugated to these particles to increase the internalization, 
while drugs like chloroquine have been encapsulated within these particles to investigate 
controlled release. Mitra et al. have used chitosan to encapsulate doxorubicin, a highly 
toxic chemotherapeutic drug.
[143]
 For encapsulation they first conjugated doxorubicin 
with dextran. This drug-dextran conjugate readily formed particles when mixed with 
chitosan. In vivo studies then showed that the chitosan-drug conjugate circulated in the 
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blood longer than the drug alone and also that the conjugate decreased the size of tumor 
to a larger extent than the free drug. 
In a very recent example of using soft polymeric nanoparticles bioconjugates for 
targeted drug delivery in vivo, Langer and coworkers used a nanoparticle construct of 
biocompatible and biodegradable poly(D,L-lactic-co-glycolic acid)-block-poly(ethylene 
glycol) (PLGA-PEG).
[144]
 PLGA-b-PEG copolymers having terminal carboxyl groups 
were precipitated into nanoparticles in presence of the cancer therapy agent docetaxel, 
resulting in the encapsulation of the drug within the nanoparticles. With an aim to target 
the particles specifically to cancer cells, the terminal carboxyl groups on the 
nanoparticles surface were conjugated to RNA oligonucleotide aptamers (specific to 
PSMA proteins expressed on the surface of LNCaP prostate epithelial cancer cell) by 
carbodiimide coupling chemistry. Animal studies showed that the aptamer bioconjugate 
nanoparticle results in complete shrinkage of the tumor after a single intratumoral 
injection of maximal tolerated dose for i.v. administered docetaxel. The nanoparticle 
synthesis involves FDA approved materials and the technique thus holds promise for 
clinical trials of the effectiveness of polymeric nanoparticles bioconjugates in cancer 
therapy. Additional advantages for clinical studies include small size, facile synthesis, 
relative stability and immunogenic nature of the targeting agents.  
Hubbell and coworkers synthesized nanoparticles by emulsion polymerization and 
evaluated their performance as circulating carriers.
[145]
 Particles were composed of cross-
linked poly(propylene sulfide) and Pluronic F-127 was used as a surfactant, which 
becomes entangled in the network. This creates a PEGylated outer surface on the 
nanoparticles. Two particle sizes were synthesized; 40 nm and 100 nm in diameter. The 
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nanoparticles were injected into the tail vein of mice, and the smaller size particles have a 
blood half-life of 6 h versus a half-life of 2.9 h for the larger particles. Longer circulation 
of nanoparticles can lead to potential as drug carriers. 
Zhang and Mirsa have synthesized a functionalized Fe3O4 conjugated with 
doxorubicin, encapsulated it in a thermosensitive polymer and studied drug release from 
the particles. The magnetic Fe3O4 nanoparticles were functionalized with methyl-3-
mercaptopropionate, and the doxorubicin was then conjugated through a hydrazinolysis 
reaction. The outer polymer was synthesized in several steps, including free radical 
copolymerization and hydrazinolysis reactions. The magnetic nanoparticles were then 
mixed with the polymer and 1, 6-diaminohexane at a ratio of 2:3:1 in DMSO to 
encapsulate the drug-conjugated nanoparticles. The release of the drug from the particles 
was then studied. At 37 ºC, the release of the drug is at a high rate for 5 h, then a 
sustained release is seen over 48 h. Acidic conditions also lead to favorable drug release, 
making these particles potential sustained-release drug carriers.
[146]
   
  
1.3.2. Encapsulation and Microreactors 
 The large internal free volume and hydrophilicity of hydrogels makes them useful 
in encapsulation of various species such as DNA, RNA, small molecules, and proteins. 
When encapsulated, the hydrogel network can protect these species or release them in a 
controlled manner, as discussed previously. In this section we will discuss the 
encapsulating property of microgels for applications other than drug delivery. 
 It has been observed that mass transport rates of small molecules in hydrogels 
depend on the pore size, where larger pore sizes make it easier for the molecules to 
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diffuse in the gel. In case of thermoresponsive microgels, a temperature dependent 
diffusion is observed. At T < VPTT higher diffusion rates are observed than at T > 
VPTT, due to a decrease in pore size of the polymer network at higher temperatures. 
Also, the charge on the polymer network is an important parameter, where it is easier to 
encapsulate molecules that are oppositely charged with respect to the polymer. In 
addition to this, a hydrophobic polymer network will enhance the encapsulation of a 
hydrophobic moiety. 
 Akiyoshi et al. have used cholesterol bearing pullulans to encapsulate various 
proteins and peptides, e.g. insulin in which case they observed the conformational 
stability of the macromolecule using circular dichroism (CD) spectroscopy.
[147, 148]
 No 
spontaneous release of insulin was observed from the nanoparticle, suggesting a very 
strong complexation in the macromolecular assembly. They observed that free insulin 
aggregated when subjected to heating but the encapsulated protein resisted such 
aggregation. They further studied the insulin stability against α-chymotrypsin activity, 
which degrades insulin. The pullulan-insulin complex resisted degradation to a much 
larger extent than the free insulin. Hence this system can potentially be used for 
protection of the species of interest. Similarly, they have used pullulans as molecular 
chaperones for an enzyme.
[149]
 Carbonic anhydrase B is an enzyme that denatures and 
aggregates at high temperature. The authors complexed the enzyme with the pullulans in 
the enzyme’s denatured state. The complex was cooled and the enzyme was released 




Developing strategies for controlling the permeability of hollow nanoparticles can 
allow their use as nanoreactors. Advancement in this respect has been achieved by Meier 
and coworkers, who synthesized nanoreactors based on ABA-triblock copolymer 
micelles.
 [150]
 For designing of the nanoreactors, the researchers used amphiphilic triblock 
polymers and assembled a natural membrane channel protein, porin OmpF in situ with 
the micellar assembly of the triblock polymer, yielding porin-containing nanoparticles. 
The membrane protein serves as a channel for permeation of small hydrophilic molecules 
through the hydrophobic region of the polymeric micelles. An enzyme β-lactamase was 
also encapsulated in the inside of the porin-containing micellar nanoparticles. The 
micelles were made stable by cross-linking the underlying triblock copolymers by 
photopolymerizing the reactive end groups of the blocks. To verify enzyme activity, the 
researchers studied the hydrolysis of the antibiotic ampicillin by the encapsulated enzyme 
by monitoring the hydrolysis product formed (ampicillinoic acid) that subsequently 
diffused out of the nanoreactors. They observed that the enzyme retained its activity even 
while encapsulated in the micelle. No reaction was observed without the porin channels 
because of the inability of the ampicillin to enter the hydrophilic interior (where the 
enzyme was located) of the micelle through the thick hydrophobic shell. However the 
hydrolysis rate due to the encapsulated enzyme was lower than that due to a free enzyme. 
This is due to the limited diffusion of the ampicillin and the ampicillinoic acid due to the 
low number of narrow porin channels in the shell. Based on a similar scheme, Gelder and 
coworkers formed a similar nanoreactor encapsulating a prodrug-activating enzyme and 





1.3.3. Analytical Applications  
 Given the ability to synthesize a variety of responsive hydrogel structures, 
chemical and biological sensing applications remains an intriguing application. One of 
the earliest types of hydrogel nanoparticle employed in “sensing” was a pH responsive 
particle. The simplest method of fabrication involves the use of pH responsive moiety, 
such as a weak acid, which can be copolymerized into the polymer network. At low pH, 
the acid groups are protonated and the particles will be in a somewhat condensed form, 
while at a higher pH where the acid groups are deprotonated, the particles adopt a 
swollen structure due to Coulombic repulsion among the negatively charged regions and 
a change in the free energy of mixing with water. Similarly, charged microgels are 
responsive to ionic strength, where an oppositely charged ion neutralizes the charge and 
causes the gel to shrink. Similar approaches have enabled the fabrication of cross-linked 
block co-polymer micelles with pH responsivity. While this approach appears to be a 
generalizable motif by which one can imagine designing hydrogel nanoparticles that 
“sense” their surroundings, very little else has been done on creating hydrogel 
nanoparticles for real chemical sensing applications. However, a few examples are 
beginning to emerge. For example, we have demonstrated that hydrogel microstructures 
can be rendered sensitive to protein binding provided the interaction is multivalent and 
therefore results in an increase in the microgel cross-link density.
[42]
 This approach has 
been extended to reversible biosensors based on antibody:antigen displacement or 
competitive binding. In this example, we have first incubated antigen-presenting 
microgels with antibodies, which then bind to the microgel surface. These microgels also 
possess a photoaffinity labels (benzophenone) which can then be photoactivated, thereby 
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photo-coupling the antibodies to the microgels. The antibody-antigen based cross-links 
can then be reversibly switched by exposure to free antigen, which displaces the cross-
link and swells the particle. This approach has been coupled to a microlensing technology 
that allows for rapid, label free readout of the sensor response.
[152]
  
 In addition to these applications, microgels have been used for the separation of 
proteins from complex media. Kawaguchi et al. reported that proteins could be separated 
using thermoresponsive microgels.
[116]
 They used regular pNIPAm microgels and 
observed that at T > VPTT larger amounts of protein bound to the particles than at T < 
VPTT. The higher degree of protein adsorption at T > VPTT was attributed to 
hydrophobic interaction between the protein and dehydrated polymer. In an approach that 
utilized Coulombic interactions, Elaissari et al. used cationically charged pNIPAm 
microgels for extraction of RNA. It was observed that the interaction between the 
cationic particles and negatively charged RNA decreased with an increase in pH, ionic 
strength and temperature, thereby indicating that adsorption was mainly governed by 
electrostatics.
[153]
 In an immunoseparation study, Kondo et al. synthesized 
poly(styrene/NIPAm/glycidyl methacrylate) microgels. These particles were designed 
such that they flocculated at high temperature and at high ionic strength. Using the 
glycidyl methacrylate co-monomer as a chemical handle for chemoligation, BSA was 
coupled to the particles, which were then used for immunoseparation of anti-BSA from 
serum. After incubation with the serum, the particles were separated by flocculation.
[154]
 
Similarly, particles that contained magnetite were used by this group for separation and 





Hydrogel nanoparticles have also been employed in a molecularly imprinted 
polymer (MIP) scheme. The principle behind MIP is based on both shape and molecular-
recognition templating. When the polymerization is carried out in the presence of 
“template” molecules, it is envisioned that the polymer will rigidify around that template, 
forming a cavity that is optimized for binding of that molecule. After the templates are 
removed, it is hoped that the cavity retains that shape and is able to bind and detect that 
particular molecule or similar molecules in a complex mixture. Ye et al. have synthesized 
hydrogel nanoparticles in the presence of theophylline and 17 β-estradiol. The sensing 
molecules were dissolved in the mixture of methacrylic acid and trimethylolpropane 
trimethacrylate and then polymerized either thermally or by UV irradiation. In these 
studies they used radio ligand binding analysis to determine the sensitivity and selectivity 
of analyte binding.
[156]
 Competition binding experiments showed high selectivity for the 
analyte. 
Daunert and coworkers in a recent report showed how biological processes can be 
used to tailor the response of hydrogels.
[157]
 A biological recognition unit was 
incorporated into the hydrogel structure and conformational changes in the unit in 
response to external factors resulted in volume changes in the hydrogel. Calmodulin 
(CaM), a protein, which undergoes different conformational changes on binding with 
Ca
2+ 
(native to dumbbell-like), certain peptides or a certain class of drugs like 
phenothiazines (native to more constricted), was incorporated in the hydrogel by 
genetically engineering the protein to have a cysteine residue at the C-terminus, which 
was further conjugated to an allylamine in order to attain oriented immobilization of the 
protein in the hydrogel network. For incorporating phenothiazine in the polymer network, 
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a derivative having polymerizable acrylate group was synthesized. Free radical 
polymerization of the polymerizable protein and drug, an acrylamide monomer and a 
cross-linker N,N
’
-methylenebis(acrylamide) resulted in the desired hydrogels. The 
hydrogel showed reversible swelling which was dependent on the concentration of Ca
2+
. 
On saturating the hydrogel with Ca
2+
, the resulting conformational change in CaM and 
the phenothiazine binding site of CaM became accessible to the immobilized drug 
resulting in the increased cross-linking and shrinkage of the hydrogel. The gel swelled on 
Ca
2+ 
removal, resulting from the release of the drug derivative from the binding site and 
also since the water uptake property of the polymer was changed due to modification of 
the hydrophobic surface of the protein. The hydrogel also showed response to 
phenothiazines. When the hydrogel was treated with free phenothiazine 
(chlorpromazine), the hydrogel swelled due the competitive binding of the free drug 
replacing the bound immobilized drug from the binding site of the conjugated protein. 
These protein and drug modified hydrogel biomaterials hold promise for microactuators 
and in microfluidics, as also demonstrated by the authors. 
Miyata, et al., have demonstrated gels that respond to tumor markers.
[158]
 The gels 
were prepared by biomolecular imprinting, which involves functionalizing the gels with 
ligands that will interact and form cross-links upon recognition of a target molecule.  In 
this work, the gels responded to the tumor specific marker α-fetoprotein, AFP.  AFP is a 
glycoprotein used for serum diagnosis of primary hepotoma.  Lectin (Con A) and 
polyclonal anti-AFP antibody was conjugated with N-succinimidylacrylate (NSA) to 
form polymerizable vinyl groups and the gels were formed by copolymerizing these 
groups with acrylamide in the presence of template AFP.  This forms a lectin-AFP-
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antibody complex, and the removal of the AFP creates the AFP-imprinted gel.  It was 
shown that AFP-imprinted gels shrank upon exposure to AFP, as the lectin-AFP-antibody 
forms a gel cross-linking complex.  Nonimprinted gels experienced slight swelling in 
AFP solutions.  The gels were also shown to be specific to the glycoprotein, as the gels 
did not shrink, but actually swelled in ovalbumin solutions as well.  
Wooley and co-workers have developed gadolinium-labeled shell-cross-linked 
nanoparticles for magnetic resonance imaging (MRI) applications.
[159]
 Gadolinium 
combined with the chelating agent diethylenetriaminepentaacetic acid (DTPA) is the 
predominant contrast agent used today for MRI.  It is important to stabilize these agents 
within biological environments since gadolinium is highly toxic.  The Wooley group 
complexed the gadolinium chelates to SCK nanoparticles to form particles with 
hydrodynamic diameters of 40 ± 3 nm.  The SCKs possess a core-shell morphology 
comprised of diblock copolymers of poly(acrylic acid) and poly(methyl acrylate) after 
which the Gd-chelate was conjugated to the SCKs by carbodiimide coupling.  
Khan has prepared magnetic nanoparticles of ~110 nm in diameter by a 
coprecipitation polymerization.
[160]
 These particles have a potential use as an MRI 
contrast agent or as a magnetically guided drug delivery agent. Oleic acid was reacted 
with the –OH groups on the surface of iron oxide particles. The prebound oleic acid 
allows excess oleic acid to adsorb, forming a hydrophobic shell. These particles will exist 
in aqueous phase after being dissolved in an NH4OH solution, as the outer shell is 
transformed to an ammonium salt of oleic acid. A copolymer microgel shell of pNIPAm 




1.3.4. Biomaterials                     
 Perhaps the broadest definition of biomaterials comes from the National Institutes 
of Health Consensus Development Conference: “[a biomaterial is] any substance (other 
than a drug) or combination of substances, synthetic or natural in origin, which can be 
used for any period of time, as a whole or part of a system which treats, augments or 
replaces any tissue, organ or function of the body”.
[161]
 Research in the field of 
biomaterials is often linked to developing a more biocompatible system, such as making 
an implant or surgical device less damaging to the body. In case of hydrogels, much of 
the effort has been put in coating the surface of the implants or devices with polymers or 
bulk gels. With the advent of responsive hydrogels, many researchers began working on 
making “smarter biomaterials”, where these materials can sense a change in the 
environment and respond in a programmed fashion to it. In this section we describe a few 
of those examples pertaining specifically to hydrogel nanoparticles. 
As mentioned previously, Kawaguchi has studied the interaction of proteins with 
microgels extensively.
[116, 162, 163]
 For example, the group has studied the effect of 
temperature on the non-specific adsorption of proteins to thermoresponsive microgels. 
They have also investigated the activity of enzymes that are covalently bound to the 
microgels. In one example they attached trypsin peroxidase to pNIPAm microgels and 
studied its activity as a function of temperature.
[164]
 The enzyme activity decreased with 
increase in temperature due to the decrease in the pore size. This caused the decrease in 
the rate of diffusion of substrate to the enzyme. They also studied a similar system with a 
small molecule, ubiquinone, attached to the particle and observed similar temperature 
dependent results. Duracher et al. have studied the adsorption of HIV-1 capsid protein 
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p24 on polystyrene-core-pNIPAm-shell particles.
[165]
 As predicted by numerous studies, 
they observed higher adsorption at T > VPTT of pNIPAm due to hydrophobic 
interactions. Similarly Urakami et al. studied the phagocytosis of polystyrene-co-
polyacrylamide gel particles as a function of hydrophobicity. They observed that 
phagocytosis by granulocytes increased with the increase in polystyrene content of the 
particles, again presumably due to an increase in hydrophobic association with the 
granulocyte.
[166]
 In similar studies, Kimhi and Bianco-Peled used isothermal titration 
calorimetry (ITC) to study the adsorption of small molecules (aspartic acid and valine) to 
pNIPAm microgels as a function of temperature.
[167]
 They found that at 25 °C aspartic 
acid binds strongly to the polymer particles due to formation of hydrogen bonds and at 37 
°C valine binds strongly due to the hydrophobic effect. 
More advanced architectures can be prepared that take advantage of biocatalytic 
systems. For example, Ogawa et al. have synthesized pNIPAm microgels containing a 
pendant vinyl imidazole side-chain, which again allows for pH-tunable gel swelling.
[40]
 
The enzyme urease, which catalyses the hydrolysis of urea into ammonia, was then 
physically entrapped in the particles. As the enzyme produced ammonia, the pH of the 
medium decreased. Hence, in the presence of urea the particles shrank due to increase in 
pH and subsequent deprotonation of the imidazole unit. When the substrate was removed, 
the particles swelled to their original size as the local pH equilibrated with the pH of the 
surrounding bath. To demonstrate the potential utility of such a biomechanical system, 
the authors incorporated these particles into a membrane. Upon introduction of urea to 
one of the solvent reservoirs, they observed that the permeability of the membrane 
increased as the particles shrank. 
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 An important aspect of many implanted biomaterials relates to the ability of cells 
to adsorb and proliferate on the material surface. It is clear that even materials with low 
surface energies and hence low degrees of non-specific protein adsorption can tend to 
foul over time in cell culture or following implantation. Hence, it is important to evaluate 
fouling of biomaterials as well as to arrive at new strategies for mediating cellular 
recruitment at synthetic surfaces. Thus, in addition to the aforementioned protein 
adsorption studies, Kawaguchi and coworkers have also studied the effect of cell binding 
to thermoresponsive particles on a solid surface.
[116]
 They first deposited pNIPAm 
microspheres on a plate to produce a 2D array upon which the cell culture medium was 
seeded. They observed that the cells produced more reactive oxygen species at 37 °C than 
at 25 °C, indicating that the cells are under more mechanical stress at the higher 
temperature. This is presumably due to stronger attachment at T > VPTT. They also 
observed that the amount of reactive oxygen species produced when the system was 
heated from 25 °C to 37 °C was much higher than just incubation at 37 °C. This they 
attributed to the stimulus inflicted by the dynamic deswelling process. In addition to this 
system they have also used a ligand: receptor system to study the mechanical stress on 
the cells.
[116]
 Our group has fabricated particles in which the adsorption of the proteins to 
the particles is reduced by using PEG grafting.
[168]
 In this report we used pNIPAm-
core/pNIPAm-shell particles and attached PEG either to the core or to the shell by co-
polymerization of PEG-monomethacrylate. Reduced protein adsorption was observed for 
both the core and shell-grafted PEG particles. It was further observed by NMR and 
protein adsorption measurements that at high temperature the PEG chains phase separate 
to the particle surface, and because of the polymer’s hydrophilicity reduce protein 
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adsorption. In case of the particles in which the PEG is attached to the core, the PEG 
chains are able to penetrate the shell and phase separate to the surface, thus reducing the 
surface energy of the deswollen particles. 
The Lyon group has prepared microgels for use as coatings for poly(ethylene 
terephthalate) (PET) discs to create non-fouling surfaces.
[169]
  Microgels were synthesized 
by free-radical precipitation polymerization with pNIPAm as the main monomer and 
poly(ethylene glycol) diacrylate as the cross-linker.  The PET discs were functionalized 
with polyacrylic acid and benzophenone, and the particles were deposited by spin-
coating. The discs were then irradiated with UV light to covalently link the particles to 
the PET. The microgels act to give the PET discs non-fouling property, as the bare PET 
support high levels of cell adhesion, while microgel coated PETs show no macrophage 
adhesion at 48 h.  
 The development of materials that can interact with cells and proteins is important 
for drug delivery devices and extracellular matrix (ECM) mimicking.  Protease 
responsive hydrogels have been described in the literature, such as those developed by 
Moore and co-workers.
[170]
 In this work, hydrogel particles that are degraded by α-
chymotrypsin were developed.  They described a conjugation technique by which a 
disulfide transfer reaction under acidic conditions that allows for a cross-liner that 
contains peptide sequences to be synthesized.  A methacrylamide containing a CYKC 
sequence was incorporated into polyacrylamide hydrogels.  Hydrogels containing the 
CYKC cross-linker, which is sensitive to chymotrypsin, completely degraded in 20 
minutes in the presence of the enzyme, while hydrogels containing a chymotrypsin-
insensitive CSKC cross-linker remained intact.   
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In another example of core/shell particles that may have utility in biomaterials 
applications, the Lyon group has prepared a system in which the shell acts a barrier 
between the protein in the solution and a core-localized ligand buried under the shell.
[171]
 
In this case a core has been synthesized, to which biotin is attached, followed by addition 
of a shell containing a degradable cross-linker. Initially the cross-linker density is high 
enough that the pore sizes are smaller than the size of the protein avidin. As the cross-
linker is degraded, the average pore size increases and allows permeation of avidin to the 
core, where it can bind to biotin. We have also observed protein size dependent 
permeation i.e. for larger proteins, more cross-links have to be degraded to allow for 
binding. These systems are interesting from the view of the topological complexity and 
also because they may be a model system for a particle that can “express” a particular 
functionality at the surface following a biological or chemical signal, which disrupts 
shell-localized cross-links.  
An interesting approach taken by researchers to form nanomaterials having 
unique properties is the conjugation of nanoparticles with ligands, which have the ability 
to mediate inter-particle interactions with substrates and direct their self assembly to form 
higher ordered nanostructures. Because of the ease of physical and chemical 
modification, directed self assembly of polymeric nanoparticles gives chemists an 
advantage of controlling and manipulating the shape and composition of the assembled 
material. Wooley and coworkers demonstrated that, conjugation of a peptide nucleic acid 
(PNA) to the surface of shell-cross-linked nanoparticles (by carbodiimide coupling 
methods) provides functionality for controlled self assembly of the nanoparticles into 
large assemblies.
[172] 
Higher order assemblies were obtained by inter-particle 
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complimentary base pairing of the PNA sequences on the nanoparticles. The size of the 
assemblies was controlled by controlling the number of PNAs on each nanoparticle. This 
assembly process has demonstrated an interesting way to assemble soft polymeric 
nanoparticles into desired arrays. One can also imagine having PNAs on the solid 
substrate surface that are complementary to the PNAs on the nanoparticles and thus 
directing the assembly of the nanoparticles onto a patterned substrate to form an array of 
soft materials with diverse functional regions.  
 
1.4 Conclusions and Outlook 
 Towards the end of the last century, it was commonly thought that the term 
“nanotechnology” was coined exclusively for “hard materials” but this changed as 
polymeric materials became more common ingredients in nanometric systems. In this 
chapter we have discussed various types of hydrogel nanoparticles and their applications 
in nanotechnology. As more and more research is carried out in this field, it becomes 
clearer that these materials hold great promise on their own, and as a bridge between 
more traditional nanostructures and biological systems. For example, gels that respond to 
a change in their environment are potentially useful in the context of truly bioresponsive 
structures that may enable us to manipulate natural systems in a rational fashion.  
Although many groups have worked in this field, many of the potential resources 
are still untapped. There are opportunities for new efforts in advanced synthetic 
approaches to complex hydrogel nanomaterials, both in colloid synthesis (e.g. size and 
shape control) and in new chemoligation methods for controlled bioconjugate synthesis. 
The rational design of multifunctional architectures will be enabled by such efforts, 
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thereby allowing the improvement of current applications areas, as well as the 
implementation of hydrogels in new arenas. In the case of core/shell particles reported by 
our group and others, the range of potential applications in which such materials can be 
applied is just beginning to be uncovered. Early studies of the detailed structure/function 
relationships in hydrogel particles are now leading to the design of primitive applications-
oriented nanomaterials. These proof-of-concept studies can then feed back into the 
synthetic labs and provide guidance for the synthesis of the second generation of 
materials. In parallel, it will become increasingly important to perform detailed studies of 
cytotoxicity, immunogenicity, and pharamcokinetics, if these materials are to be 
employed in biotech applications. Finally, ground level integration between chemists, 
biochemists, engineers, and clinicians is desired to enable the design, synthesis, and 
testing of structures that are truly applicable in clinical applications such as drug delivery 
devices, implantable biomaterials, biosensors/assays, and targeted chemotherapeutic 
formulations. The following chapters will deal with our work in advancing the 
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THE USE OF AFFF-MALLS TO CHARACTERIZE MICROGEL 
PARTICLE SIZE  
  
2.1 Introduction 
Particle sizing can be accomplished by a number of analytical methods. These 
include optical or electron microscopy, Coulter counter, neutron scattering, and photon 
correlation spectroscopy. There are also methods based on the physical separation of 
particles, such as field flow fractionation (FFF) or capillary hydrodynamic 
chromatography (CHDF). All of these methods have problems however, which can lead 
to inaccuracy in measurements.
[1]
 
Optical microscopic techniques are limited in terms of particle size, as particles 
below 500 nm in diameter are very difficult to image. Transmission electron microscopy 
(TEM) does not encounter the same size problems, but the disadvantages include 
relatively slow measurement speed and difficulty in imaging soft nanoparticles such as 
hydrogels.
[1-3]
 The drawback to using a Coulter counter is that the instrument only sizes 
particles one at a time, not allowing for the sizing of a large ensemble of particles.
[1]
 
Small angle neutron scattering (SANS) can size particles on the nanometer length scale, 
but can be difficult as a neutron source is required, meaning experiments are done at large 
scale facilities. The main disadvantage of PCS is that data analysis requires a number of 
assumptions in regards to the particle distribution.
[1]
 The data can be skewed if there is a 
broad distribution of particles, or if there is a multimodal particle set.  
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A well-established method for absolute determination of root mean square radii 
(rms) is multi-angle laser light scattering (MALLS).
[1-3]
 MALLS, when used on 
unseparated samples, will result in rms radius and mean molar mass of the particles. 
MALLS is classical light scattering, performed at several angles. It involves measuring 
the amount of light scattered by a sample at these angles to the incident laser. The 
scattering as a function of angle is called Rayleigh scattering, which for macromolecules 
has an angular dependence. It can give the rms radius, molar mass, and second virial 
coefficient (A2). The theory used to describe the scattering of light by macromolecules in 
solution is called the Rayleigh-Gans-Debye theory.  
Particles scatter light at various angles due to differences in each particle, leading 
to constructive or deconstructive interference. By measuring the interference at multiple 
angles, the angular dependence of scattered light can be determined. Knowing the angular 
dependence of scattered light allows the determination of particle size, measured as rms 
radius. The rms radius is a measure of particle size weighted by the mass distribution 
about the particle’s center mass, and can also be called radius of gyration (Rz).  




 condensed the Rayleigh-Gans-Debye 



















where R(θ,c) is excess Rayleigh ratio of solution as a function of scattering angle θ and 
concentration c, c is solute concentration, Mw is weight average molar mass, A2 is second 
virial coefficient, K* is an optical constant, and P(θ) is angular dependence of scattered 
light. P(θ) can be related to the rms radius by expansion to first order. 
To measure the molar mass of particles in solution, it is necessary to know the 
change in refractive index (∆n) with the change in molecular concentration (∆c). This is 
known as the dn/dc, and can be measured with a refractive index detector. It is necessary 
to measure dn/dc because as a laser hits a particle in solution, an oscillating dipole is 
induced within the particle, which scatters the light. The intensity of scattered light to a 
detector is dependent on the dn/dc of the particles. By using the above equation, particle 
mass can also be determined.
[1, 6]
  
MALLS can be used to measure an ensemble of particles if combined with a 
separation technique. The separation will fractionate the particles in slices, each with 
narrow size distributions, which will be measured by MALLS. Asymmetric field flow 
fractionation (AFFF) is a separation technique based on hydrodynamic principles.
[1, 3, 7]
 
Particles flow across a membrane, carried by a channel flow. The separation occurs as a 
cross flow acts perpendicularly to the channel flow, pushing the particles against the 
membrane. Translational diffusion causes the particles to migrate back into the channel 
flow. By choosing the appropriate cross flow, the particles can elute out of the channel, 
and on to a detector, such as a UV-vis or MALLS instrument. Particle retention against 
the membrane is a function of its size, as smaller particles will flow off of the membrane 




2.1.1 Uses of AFFF-MALLS 
In this chapter, we will look at the many ways AFFF-MALLS has been used. 
Palmer and coworkers have used AFFF-MALLS to study the size, shape, and 
encapsulation efficiency of liposome-encapsulated actin-hemoglobin dispersions 
(LEAcHb).
[8]
 These LEAcHb dispersions were developed as potential blood substitutes, 
as a way to replace normal blood transfusions. Since cell free hemoglobin solutions 
induce vasoconstriction and renal toxicity, liposome-encapsulated hemoglobin systems 
have been developed. Liposomes were prepared via extrusion of a lipid film through 
polycarbonate membrane pores of either 400 or 600 nm in diameter. The dispersions 
were prepared as plain liposomes, liposome-encapsulated hemoglobin (LEHb), liposome-
encapsulated actin (LEAc) or liposome-encapsulated actin-hemoglobin (LEAcHb). The 
shape, size, and encapsulation efficiency were measure at the same time by the AFFF-
MALLS. Shapes were determined by fitting MALLS spectra to various form factors. 
Empty liposomes were spherical in shape, while liposomes containing actin were formed 
as a disk-like assembly. The size distributions were shown to increase for plain liposomes 
to liposomes containing hemoglobin, however the size did not change much for actin-
containing particles that did or did not contain Hb. The same trends were seen for both 
liposomes extruded through the 400 or the 600 nm pore membranes. To determine 
encapsulation efficiency, the differential refractive index of eluting Hb was measured. 
The unencapsulated Hb was separated from the liposomes by the AFFF. LEAcHb 
prepared through 400 nm pore membranes had a Hb encapsulation efficiency of ~ 30%. 
LEAcHb prepared through 600 nm pore membranes showed an encapsulation efficiency 
of 46%.  
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Patton and Palmer have also used AFFF-MALLS to study “lipogels” as artificial 
blood substitutes.
[9]
 In this work, the particles were synthesized as poly(N-
isopropylacrylamide) (pNIPAm) or poly(acrylamide) (pAm) hydrogels were prepared via 
UV-induced photopolymerization inside of a liposomal reactor. Egg-ʟ-α-
phosphatidylcholine (EPC) films were rehydrated in bovine hemoglobin, along with 
NIPAm or Am, cross-linker, and a photoinitiator in either Tris-HCl or phosphate buffered 
saline (PBS). Liposomes were formed by agitating the lipid film and then extruding the 
film through 200 nm pore diameter polycarbonate membranes, and then UV irradiation 
used to polymerize the hydrogels. AFFF-MALLS was then used to determine the particle 
size and shape. The lipogels were shown to be fairly monodisperse, as none of the 
constructs had a polydispersity index of much greater than 1. Also, the encapsulation of 
additional species did not effect the size, but lipogels extruded in PBS were larger but 
more monodisperse than those extruded in Tris. The pNIPAm and pAm lipogels ranged 
from 131 to 141 nm in radius. To determine shape, Rz/Rh was measured. While a ratio of 
0.77 is seen for solid spheres, hollow spheres have an Rz/Rh near 1. Both pNIPAm and 
pAm lipogels had Rz/Rh ≤ 1. The authors deduce from this that both sets of lipogels were 
spherical particles.  
Middleberg and coworkers developed virus-like particles (VLPs) and used AFFF-
MALLS to study their characteristics.
[10]
 VLPs are formed by self-assembly of viral 
structural proteins into biomolecular nanoparticles. VLPs have gained interested recently 
as a vaccine has been successfully developed against human papillomavirus.
[11, 12]
 An 
important issue involving VLPs is to have batch-to-batch consistency for regulatory 
acceptance. The use of AFFF-MALLS allows for quick and reliable characterization of 
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the VLPs. Marine polyomavirus VP1 DNA sequence was cloned into vectors and 
expressed in Spodoptera frugiperda (Sf9) cells and Escherichia coli (E. coli) cells. VLPs 
were collected from the cells. AFFF separation was done with a cross flow of 0.75 
mL/min and the VLP fractions were then characterized by MALLS. Fraction sizes ranged 
up to 100 nm in radius with 69% of the VLPs from Sf9 between 15 and 35 nm. Less 
aggregation was seen from VLPs from E. coli, with 96% having a radius between 15 and 
35 nm. To determine if there was VLP aggregation, cross flow was increased up to 1.50 
mL/min to completely immobilize the particles on the membrane. There was no 
significant aggregation seen, even at these high cross flows. AFFF-MALLS was also 
used to monitor changes in the VLP quaternary structure. Differences in quaternary 
structure were evident from the fractions eluting after VLP disassembly. This 
disassembly is important for applications such as purification of encapsulated 
contaminants. This disassembly can thus be monitored by AFFF-MALLS.  
Schimpf and coworkers have used AFFF-MALLS to study aggregation of the 
protein calsequestrin.
[13]
 Calsequestin (CSQ) is a protein that functions both in the 
regulated release and sequestration of Ca
2+
 from the sarcoplasmic reticulum. CSQ, in 
response to increase Ca
2+
 concentration, forms aggregates in the form of dimers, then 
tetramers, and onto higher order aggregates. CSQ aggregation can be inhibited by 
increased K
+
 concentration. Some small molecules are known to bind to CSQ, which 
could lead to cardiotoxic side effects. The authors have studied the aggregation of CSQ in 




 as well as the small molecule trifluoperazine (TFP). Canine 
cardiac CSQ was expressed in E. coli as an expression vector and purified. A cross flow 
of 2 mL/min that declined to 0 mL/min was used. The fractions eluted to the MALLS, 
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where molar mass was determined using light scattering and differential refractive index. 
In the presence of 3mM Ca
2+
 and 500 mM K
+
, 2 primary species eluted, with the masses 
indicating the species were dimers and tetramers. As K
+
 is increased, the amount of 
tetramer decreases. When K
+
 is held constant and Ca
2+
 concentration is increased, more 





concentrations were held constant at 3 mM and 300 mM, respectively, while TFP was 
added. As TFP in increased, CSQ distribution shifts towards tetramer and hexamer 
formation. Thus, their findings indicate that small molecules like TFP can lead to CSQ 
aggregation. 
Baalousha et al. have studied the size and shape of natural colloids. Natural soil 
colloids are important for contaminant adsorption, transport, and sedimentation in the 
aquatic environment.
[14]
 These colloids tend to have broad size distributions and can be 
any of a number of shapes. These characteristics control their mobility and how they 
interact with the environment. The use of AFFF-MALLS allows for shape and size 
determination of these colloids. The AFFF can accurately separate the many fractions of 
colloids, and as they elute to the MALLS, the size distributions of these fractions can be 
measured. Samples were obtained from drilled soil cores in northern Germany, and 
divided into two sample sets. An AFFF channel flow of 1.5 mL/min and cross flow of 
0.75 mL/min were used for particle separation. The natural colloids showed a continuous 
distribution, until the cross flow was modified. By adjusting the cross flow on subsequent 
runs, the authors could elute peaks for the different sized colloids. Three different particle 
sizes were seen: small (50-150 nm), intermediate (200-350 nm), and large (> 350 nm). 
Shaped was then inferred from Rg/Rh ratios. The small and intermediate sizes had ratios 
 
71 
of 0.85 and 0.775, respectively, suggesting spherical shapes. The large particles had 
ratios of 1.05, 2, and 2.7, depending on particle set. These suggest a deviation from 
spherical particles, toward a platelet shape.  
Citkowicz et al. have studied VLPs for DNA delivery.
[15]
 VLPs were developed 
from the VP1 protein derived from human polyoma JC-virus (JCV) as it can be used to 
target a number of different cells, such as kidney epithelial cells. VLPs were expressed in 
Sf158 insect cells. After centrifugation of the cells, the VLPs were precipitated out of the 
supernatant with 8000 MW poly(ethylene glycol). After purification of the VLPs through 
a DEAE Sepharose column, the VLPs were collected. The VLPs were then dissociated to 
remove impurities, and then packaged with a reporter DNA containing green fluorscent 
protein. AFFF-MALLS was used to characterize the VLPs. The separation and 
subsequent molar mass measurements of the VLPs showed two populations, one of the 
VLPs, and a second of aggregated VP1 proteins. Initial packaging attempts of DNA 
seemed to suggest aggregation of the VLPs, as mass and radius were much larger than 
expected. The results suggested that 5-kB plasmids could not be encapsulated. Therefore, 
a 1.6-kB linear DNA was used. The packaged VLPs had a radius of 24 nm. This was ~ 
1.5 nm larger than unpackaged VLPs. An interesting feature uncovered by AFFF-
MALLS was that the larger radii packaged VLPs actually had a smaller molar mass than 
unpackaged VLPs. The authors explain this by describing the packaged DNA was near 
the VLP capsid, leaving the center of the particle “more empty”. The rigid capsid of the 





All of these uses demonstrate the capabilities of AFFF-MALLS. The remainder of 
this chapter will describe some of the work we have done with the instrument, 
characterizing microgel changes with the AFFF-MALLS. 
 
2.1.2 Microgels 
As described in Chapter 1, hydrogel colloids, or microgels, are randomly oriented, water-
soluble, cross-linked polymer nanoparticles. This chapter will investigate responsive 
hydrogels, which can undergo a swollen to deswollen transition in response to external 
stimuli.
[16-23]
 One of the most interesting characteristics of pNIPAm-based microgels is 
the swelling/deswelling of the gels in water upon reaching the LCST. Below this 
temperature, the microgels are hydrophilic and swollen, but above this temperature, there 
is an entropically driven polymer phase transition, expelling the water and deswelling the 
gel.
[16, 19-21]
 Our group has optimized core/shell microgel synthesis over a wide range of 
sizes utilizing this behavior to drive the controlled nucleation growth of the particles. 
This behavior is also important in terms of particle characterization for this work, as we 
can use AFFF-MALLS to investigate particle sizes above and below the LCST.  
 The microgels used in this work are composed of a degradable cross-linker, N,N’-
(1,2-dihydroxyethylene)bisacrylamide (DHEA). The use of DHEA allows for 
degradation by sodium periodate, which cleaves vicinal diols.
[24]
 By cleaving the DHEA 
in the core of the core/shell microgels, particles can be made “hollow”, which will lead to 
changes in radii for the particles at 25 ºC and at temperatures above the LCST. Using the 
AFFF-MALLS, we have investigated these changes in particle size for both native 
core/shell microgels and the degraded core particles.   
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2.2 Experimental Section 
2.2.1 Materials 
All materials were purchased from Sigma-Aldrich unless otherwise noted. The 
monomer N-isopropylacrylamide (NIPAm) was recrystallized from hexane (J. T. Baker) 
before use. The cross-linkers N,N’-methylenebis(acrylamide) (BIS) and N,N’-(1,2-
dihydroxyethylene)bisacrylamide (DHEA), as well as ammonium persulfate (APS), and 
sodium dodecyl sulfate (SDS),  were all used as received. Water used in the experiments 
was distilled and then deionized using a Barnstead E-pure system operating at a 
resistance of 18 MΩ.  
 
2.2.2 Microgel core synthesis 
Microgel core particles were synthesized by free-radical precipitation 
polymerization as previously reported. In brief, monomer (NIPAm), cross-linker 
(DHEA), and surfactant (SDS) were dissolved in 100 mL of deionized water and the 
solution was then filtered. The solution was then heated to 70 ºC in a three-neck round-
bottom flask. The solution was purged with N2 gas and stirred until the temperature 
remained stable. After 15 min, the reaction was initiated by adding 1-mL solution of 
initiator (APS). The solution turned turbid, indicating successful initiation, and the 
reaction continued for 4 h. After 4 h, the solution was allowed to cool to room 




2.2.3 Microgel shell synthesis 
Core particles were used as seeds to add a hydrogel shell, as previously reported. 
Briefly, 10 mL of the core microgel solution, SDS, and deionized water were added to a 
three-neck round-bottom flask and heated to 70 ºC under N2 gas. Separately, NIPAm and 
BIS were dissolved in 5 mL of deionized H2O. This solution was added to the three-neck 
round-bottom flask. After the temperature stabilized, the reaction was initiated by the 
addition of a 1-mL solution of APS. The reaction proceeded for 4 h. After the synthesis, 
the solution was filtered through a Whatman filter paper and then centrifuged several 
times for purification.  
 
2.2.4 Core degradation 
Core degradation of the core/shell microgels was done by the addition of sodium 
periodate. Either a 1:1 or a 2X equivalent of periodate was added to the microgel 
solution. The amount of DHEA present in the particles was calculated from the pre-gel 
solution. The reaction was allowed to occur for either 2 h, or overnight, on a shaker table 
at room temperature. Particles were centrifuged after degradation to remove the degraded 
material.  
 





2.2.5.1 Static light scattering  
 In order to determine the distribution of z-average radii (Rz) for particles, multi-
angle laser light scattering (MALLS; Wyatt Technology Corporation) detection following 
asymmetric field flow fractionation (AFFF) was used. AFFF separation uses a cross-flow 
method to separate particles as a function of hydrodynamic volume. The cross-flow 
forces larger particles against a cellulose membrane, while smaller particles elute to the 
MALLS detector faster. For all separations, a cross-flow of 1.0 mL/min was used, and a 
Peltier device was used to maintain a flow cell temperature at either 25 ºC or 40 ºC. The 
MALLS detector collects light from 16 different fixed angles as a function of peak 
intensity (V) to determine Rz of the particles. ASTRA 5.1.5.0 software was used to 
determine Rz of the particles, using the Debye fit method.  
 
2.2.5.2 Photon correlation spectroscopy                               
 Microgel hydrodynamic radii (Rh) were determined by photon correlation 
spectroscopy (Protein Solutions Inc.) equipped with a Peltier temperature control device. 
Scattered light is captured by the instrument at 90º with a single-mode optical fiber 
coupled to an avalanche photodiode detector. Samples were thermally equilibrated for 10 
min, and then data was collected for at least 10 measurements with an acquisition time of 
60 s per measurement. The data was analyzed with Dynamic Software version 5.25.44 
(Protein Solutions). The hydrodynamic radii of the particles were calculated from the 





2.3 Results and Discussion  
 The work presented here is a brief overview of the results that can be obtained 
with AFFF-MALLS. The remainder of this chapter will discuss some of the interesting 
results we have seen, and more significant AFFF-MALLS data will also be presented in 
Chapter 3.  
Figure 2.1 shows the differential weight fraction of pNIPAm-co-DHEA core/shell 
microgels. This fraction represents the width of the entire peak eluting from the AFFF to 
the MALLS detector. This plot shows the excellent control we have over the synthesis, as 
the particles are extremely monodisperse. The AFFF allows for the particle separation 
before eluting to the detector, where the sizes are determined. With the monodispersity of 
this synthesis, the separation can be more highly defined by controlling the cross-flow 
across the membrane. By adjusting the cross-flow with a highly monodisperse sample, 
the particles do not elute at the same time, as they would with a polydisperse sample if a 
narrow peak is still desired. A separation to this degree with a polydisperse sample would 








Figure 2.1. Differential weight fraction plot for pNIPAm-co-DHEA/pNIPAm core/shell 
particles, as determined by AFFF-MALLS.  
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Figure 2.2 shows the cleavage of DHEA by sodium periodate (NaIO4). By using 
DHEA as a cross-linker in the core microgels, the addition of NaIO4 will degrade the core 
material, which can be removed by cleaning the particles through centrifugation and 
removing the supernatant. Since the microgels are a core/shell structure, particles will 


























Figure 2.3 shows the visual turbidity changes that take place as the core is 
degraded. Native core/shell particles (vial 1) are very turbid, while the degraded core 
particles in vial 2 are much less turbid due to the removal of the core material. The cores 
in vial 2 particles were degraded overnight. While being able to visualize the change in 








Figure 2.3. Picture of vials containing pNIPAm-co-DHEA core/pNIPAm shell microgels. 




Table 2.1 shows the changes that take place with regard to size and light 
scattering as the particle cores are degraded. At 25 ºC, core/shell particles see a slight 
increase in radius after the core is degraded. This should not be surprising as the particles 
will become more loose, as there is very little density in the core, meaning less 
connecting points to the shell which can restrict its size. As the temperature is increased 
to 40 ºC, the particles deswell, as this is above the LCST. The degraded particles see a 
more dramatic decrease in size, as the core is not there to restrict the amount of 
deswelling. At both 25 ºC and 40 ºC, particles with a degraded core show a decrease in 
intensity, as there is less density and thus less light scattered. The overall increase in 
intensity from particles at 40 ºC versus 25 ºC is based on the deswollen particles 




Table 2.1. Native and degraded core nanogel radii and peak intensity values. 
 25 ºC 40 ºC 
 Rh (nm) Rz (nm) 
Peak Intensity 
(V) Rh (nm) Rz (nm) 
Peak Intensity 
(V) 
Native Core/shell 151 126 2.3 98 82 8.5 




Another interesting feature of these particles is the Rz/Rh ratio of the native 
core/shell and degraded core particles. As stated previously, the ratio for solid sphere is 
0.77, while hollow spheres have an Rz/Rh near 1. For the native core/shell particles, the 
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Rz/Rh is 0.83. The degraded core particle ratio is slightly higher, at 0.86. While the 
difference is not huge, it does suggest that the degradation is causing the particles to 
become somewhat “hollowed out.”  
 
2.4 Conclusions 
 AFFF-MALLS is a fairly quick and reliable tool that can be used to investigate 
particles in many different ways. In this chapter, it has been shown that degradable 
microgels can be synthesized and the size and shape studied with this instrument. The 
addition of DHEA in the microgels makes the cores of the particles degradable by sodium 
periodate. AFFF-MALLS shows exceptional control over the synthesis in terms of 
polydispersity. It also shows the size differences that occur after core degradation. The 
degraded particles show the ability to deswell more at high temperatures over the native 
particles, as the core material has been removed, allowing the particles more room to 
collapse. In addition to this, the Rz/Rh ratio for the degraded particles increases over that 
of the native particles, closer to 1. This suggests more of a hollow sphere shape for the 
degraded core particles. The AFFF-MALLS has proven to be a valuable instrument in our 
lab, and the next chapter will continue to show the excellent results we have gotten from 
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SIZE CONTROLLED SYNTHESIS OF MONODISPERSED, 
CORE/SHELL NANOGELS 
 
Adapted from Blackburn, W. H.; Lyon, L. A., Size-controlled synthesis of monodisperse 
core/shell nanogels. Colloid and Polymer Science 2008, 286, (5), 563-569. 
 
In this chapter, we describe small, monodispersed nanogels (~ 50-nm radius) 
synthesized by free-radical precipitation polymerization and characterized using a suite of 
light scattering and chromatography methods. Nanogels were synthesized with either N-
isopropylacrylamide or N-isopropylmethacrylamide as the main monomer, with acrylic 
acid or 4-acrylamidofluorescein as a co-monomer and N, N’- methylenebis(acrylamide) 
as a cross-linker. By varying the surfactant and initiator concentrations, particle size was 
controlled while maintaining excellent monodispersity. An amine-containing shell was 
added to these core particles to facilitate subsequent bioconjugation. Successful 
conjugation of folic acid to the particles was demonstrated as an example of how such 
materials might be employed in a targeted drug delivery system.  
 
3.1 Introduction 
As described in the previous chapters, poly(N-isopropylacrylamide) based 
hydrogel colloids, or nanogels are widely studied.
[1-4]
  Monodispersed nanogels over a 





free-radical precipitation polymerization being the most common.
[1, 6, 8-12]
 The lower 
critical solution temperature (LCST) of pNIPAm nanogels in water is around 31 °C.  
Particles composed of poly(N-isopropylmethacrylamide) (pNIPMAm) behave in a similar 
manner, exhibiting an LCST around 44 °C, with the increased LCST arising from an 
increase in the rigidity of the pNIPMAm polymer, as is common for methacrylamides.
[13-
17]
 This behavior is important to this work due to the fact that our group has optimized 
core/shell nanogel synthesis techniques that utilize this LCST behavior to drive the 
controlled nucleation and growth of the particles.  
The focus of this chapter is related to the size control of a variety of core/shell 
nanogel constructs. Nanogels to be used for intravenous drug delivery applications such 
as targeted chemotherapy must be around 100 nm in diameter to be efficient vehicles. 
Particles of this size do not penetrate into healthy tissues, as pore sizes in the endothelia 
of blood vessels in most healthy tissues are ~2 nm, while ~6 nm pores are found in 
postcapillary venules.
[18]
 However, the same resistance to particle penetration is not 
encountered in tumor targeting, as the “leaky” discontinuous tumor vasculature has pore 
sizes ranging from 100 nm – 780 nm.
[18-20]
 Typically, this leaky vasculature enables what 
is called the “enhanced permeability and retention” (EPR) effect, which enables the 
enhanced deposition of nanoscale delivery vehicles at the site of a solid tumor.
[21-23]
 
Another problem that delivery vehicles encounter is non-specific uptake by the 
reticuloendothelial system (RES). The surface characteristics of particles can affect 
uptake by the liver, spleen, and the rest of the RES.
[24, 25]
 Hydrophilic particles tend avoid 
the RES for much longer time periods than hydrophobic particles, thereby permitting 





 Thus, both size and surface chemistry should be controllable in order to 
enable the synthesis of effective tumor targeting vehicles. 
 The nanogels used in this chapter were synthesized by free-radical precipitation 
polymerization. In this approach, a free-radical initiator is used to initiate the reaction, 
while a surfactant is used to stabilize the growing polymer globule. Classically, one 
would expect that increasing both the surfactant and initiator concentrations would lead 
to a reduction in particle size.
[26]
 Ammonium persulfate (APS) is a free radical initiator, 
and as the reaction is heated, it creates free radicals and hence growing oligoradicals that 
act as nucleation sites onto which growing polymer can add. Increasing the initiator 
concentration leads to more free radicals being formed, and this leads to an increase in 
number of particles that can potentially be formed. Since the monomer is being consumed 
by more growing particles under such conditions, the final particle size will be smaller as 
the same amount of monomer is spread among more particles. Thus, we expect that an 
increase in the initiator concentration will yield a smaller average particle size. The 
second control parameter to be explored is that of surfactant concentration. Sodium 
dodecyl sulfate (SDS) is the surfactant used in the particle syntheses described below. 
SDS acts to stabilize the growing nuclei against aggregation early in the reaction. Thus, at 
lower [SDS], particles formed in the early stages of the reaction aggregate to form larger 
particles, decreasing the number of particles that are formed in a reaction. Conversely, an 
increase in [SDS] should increase the stability of the early nuclei, allowing them to grow 
without extensive aggregation and therefore increasing the particle number while 
decreasing the final particle size. Because of the simplicity of these reaction design 
considerations, these control parameters are commonly used in dispersion polymerization 
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to control particle size.
[26]
 In this chapter, we demonstrate the ability to synthesize small, 
monodisperse core/shell nanogel particles. The syntheses are very well controlled, and 
give us the ability to make a variety of particle sizes. We have also shown the ability to 
synthesize these small nanogels with different co-monomers thereby producing particles 
with multiple functionalities. These efforts were undertaken in support of our larger 
efforts in targeted chemotherapy wherein such synthetic control is critical. 
 
3.2 Experimental Section 
All materials were purchased from Sigma-Aldrich unless otherwise noted. The 
monomers N-isopropyl acrylamide (NIPAm) and N-isopropyl methacrylamide 
(NIPMAm) were recrystallized from hexane (J. T. Baker) before use. The cross-linker N, 
N’- methylenebis(acrylamide) (BIS), acrylic acid, N-(3-aminopropyl) methacrylamide 
hydrochloride (APMA) (Polysciences), ammonium persulfate (APS), and sodium 
dodecyl sulfate (SDS) were used as received. All water used in the experiments was 
distilled, and then deionized using a Barnstead E-pure system operating at a resistance of 
18 MΩ.  A 0.2 µm filter was used to remove particulate matter.  For folic acid 
conjugation, folic acid, 1-ethyl-3-methyl-(3-dimethylaminopropyl)carbodiimide (EDC) 
(Pierce),  and to ε-maleimidocaproic acid were used.  The fluorescent monomer 4-




3.2.1 Nanogel Core Synthesis 
 Nanogel core/shell particles were synthesized by free-radical precipitation 
polymerization as reported previously.
[10, 11]
 For all particles, the molar composition of 
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core particles was 96% NIPAm (or 96% NIPMAm), 2% BIS, and 2% AAc, or 98% 
NIPAm (or 98% NIPMAm), 2% BIS, and 0.1 mM AFA. A total monomer concentration 
of 70 mM was used for NIPAm particles, while a total concentration of 140 mM was 
used for NIPMAm particles. All polymerizations were carried out in a three-neck round 
bottom flask. As described below, various concentrations of SDS were used as the 
surfactant, and various concentrations of APS were used to initiate the reaction. In a 
typical synthesis, 100 mL of a filtered, aqueous solution of monomer, BIS, and SDS were 
added to the flask and heated to 70 °C. The solution was purged with N2 gas and stirred 
vigorously until the temperature remained stable. The AAc was then added (where 
appropriate). After 15 minutes, the reaction was initiated by adding a 1 mL solution of 
the desired concentration of APS. The solution turned turbid, indicating successful 
initiation. The reaction was allowed to continue for 4 hours while being purged by N2 gas 
with constant stirring. For particles containing AFA, the AFA was added along with the 
main monomer and cross-linker. After the synthesis, the solution was filtered through a 
Whatman filter paper. Conditions for all of the core syntheses can be found in Tables 1 
and 2. For all syntheses, the batch-to-batch size variation was within 10%. Differences 
from batch to batch can simply be attributed to slight thermal fluctuations during the 
synthesis.  
 
3.2.2 Nanogel Shell Synthesis 
Core particles were used as seeds for the addition of a shell hydrogel. The detailed 
procedure of the shell synthesis has been reported in previous publications.
[22, 23]
 In brief, 
10 mL of the core nanogel solution, 2 mM SDS, and 35 mL of deionized H20 were added 
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to a three-neck round bottom flask and heated under N2 gas to 70 °C. Separately, a 
monomer mixture with the following molar ratios was dissolved in 5 mL of deionized 
H2O: 97.5% NIPAm (or 97.5% NIPMAm), 2% BIS, and 0.5% APMA. This solution was 
added to the three-neck round bottom flask and heated to 70 °C. The reaction was 
initiated by a 1 mL solution of 0.5 mM APS and the reaction proceeded for four hours. 
Following the synthesis, the solution was filtered through a Whatman filter paper and 
then centrifuged several times for purification.  
 
3.2.3 Particle Characterization 
3.2.3.1 Static light scattering 
Multi-angle laser light scattering (MALLS) (Wyatt Technology Corporation) 
detection following asymmetric field flow fractionation (AFFF) was used to determine 
the distribution of z-average radii (Rz) for all particles. The AFFF separation method uses 
a cross flow method to separate the particles as a function of hydrodynamic volume. The 
cross flow acts to force larger particles against a cellulose membrane, while smaller 
particles elute to the MALLS detector faster. For all separations, a cross flow of 0.5 
mL/min was used. The MALLS detector is equipped with a Peltier device to maintain a 
flow cell temperature of 25 °C and collects scattered light from 16 different fixed angles 
to determine the Rz of the particles. By measuring Rz as a function of elution time, we 
construct a chromatogram that permits the determination of the weight fraction of 
particles as a function of radius, thereby providing a sample polydispersity. ASTRA 





 Particle LCST values were measured from turbidity curves collected on a steady-
state fluorescence spectrophotometer (Photon Technology International), equipped with a 
Model 814 PMT photon-counting detector. Scattering was measured through slits that 
were set to attain a spectral bandwidth of 2 nm. The scattering was measured at a 
wavelength of 600 nm, and the temperature ramp was set from 25 °C to 60 °C. An 
integration time of 1 s was used and data was collected every 0.1 °C, with the 
temperature increasing at a rate of 1 °C per minute.   
 
3.2.4 Folic acid conjugation 
 Nanogel core/shell particles were conjugated with folic acid by a method 
previously described by Dube et al.
[28]
 The core/shell nanogel solution was freeze-dried 
and then resuspended in 40 mL of 10 mM phosphate buffer pH 4.7. A 2:1 molar ratio of 
folic acid to amine in the shell was dissolved in 1 mL DMSO. To this, a 2X equivalent of 
EDC was added to activate the folic acid. This solution was mixed for 15 minutes, and 
then added to the core/shell nanogel solution. The reaction was stirred in the dark 
overnight. The particles were then centrifuged/resuspended several times for purification. 
 
3.2.5 Absorbance measurements 
 The absorbance of folic acid, core/shell particles, and folate-conjugated core/shell 
particles was determined using a Shimadzu UV 1601 spectrophotometer. Freeze-dried 
samples were dissolved in DMSO for absorbance measurements. 
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Table 3.1. Parameters for pNIPAm core particle syntheses. 
 
 










1 pNIPAm- 96% BIS- 2% AAc- 2% 2  2  70  86  
2 pNIPAm- 96% BIS- 2% AAc- 2% 3  3  70  73  
3 pNIPAm- 96% BIS- 2% AAc- 2% 4  4  70  53  
4 pNIPAm- 98% BIS- 2% AFA- 0.1 mM 4  4  70  57  





3.3 Results and Discussion 
Table 3.1 shows the very straightforward progression we have followed in the 
synthesis of pNIPAm nanogels. These data show our ability to make core particles 
composed of p(NIPAm-co-acrylic acid), as well as pNIPAm core particles containing 
AFA as a fluorescent marker. For pNIPAm-co-AAc core particles, a 70 mM total 
monomer concentration was used for all reactions. The surfactant and initiator 
concentrations were gradually increased until the particle size approached the target 50-
nm radius. As described above, MALLS coupled to the AFFF separation technique was 








Figure 3.1. Overlay of radius data as sample elutes to detector and is shown as voltage 
(a,c,e) for pNIPAm-co-AAc core particles, and corresponding differential weight fraction 
plots, as determined by AFFF-MALLS (b,d,f). Synthetic parameters for (a,b) are shown 





Figure 3.1, wherein highly monodisperse particle size distributions are evident from the 
differential weight fraction. Figure 3.1 also shows the overlay of the radius data with the 
raw detector signal, illustrating the high degree of monodispersity possible with these 
syntheses. The initial synthesis resulted in particles that were 86 nm in radius. This 
synthesis used 2 mM SDS and 2 mM APS.  After increasing these concentrations to 3 
mM each, the resulting particles were 73 nm in radius.  Particles of appropriate size were 
synthesized when the SDS and APS concentrations were increased to 4 mM each.  These 
particles had a radius of 53 nm. An interest in fluorescent tracking for future targeted 
chemotherapy studies led to our use of AFA as a co-monomer in the particle synthesis. 
Using the same synthesis conditions as described earlier, with the exception of 0.1 mM 
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AFA being used instead of 2 % AAc, the particles slightly increased in size to 57 nm in 
radius, still close to the desired particle size. This data is shown in Figure 3.2. A further 
attempt to decrease the core particle size was successful, (Figure 3.3) where the particle 
size was further reduced in size to 44 nm in radius for pNIPAm-co-AFA. The decrease in 
size was achieved by increasing [BIS] and decreasing the total monomer concentration. 
Increasing the [BIS] caused the particles to be more highly cross-linked, resulting in the 
tighter, smaller particles. The reduction of total monomer concentration results in smaller 








Figure 3.2. Differential weight fraction plot for pNIPAm-co-AFA core particles, as 





Figure 3.3. Differential weight fraction plots for pNIPAm-co-AFA core particles, as 




Table 3.2 shows the synthetic progression for pNIPMAm nanogel syntheses.  The 
introductory synthesis used the same conditions as that of the successful pNIPAm 
synthesis. However, using 70 mM total monomer concentration did not result in good 
particle formation. This was most likely due to the lower propagation rate constant for 
NIPMAm versus NIPAm, which would result in slower particle nucleation.
[29]
 The total 
monomer concentration was increased to 140 mM to achieve a successful synthesis. 
Since the synthesis required a higher monomer concentration, the surfactant and initiator 
concentrations had to be further increased to attain a particle size near 50 nm in radius. 
Figure 3.4 clearly shows that monodisperse particles can be made over a range of sizes 
using this straightforward synthetic approach. The progression of particle sizes is shown 
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with error bars that denote the full width of the differential weight fraction, indicating 
very monodisperse particles obtained from each synthesis. The pNIPMAm syntheses 
were also performed using AFA, for fluorescent tracking, instead of acrylic acid as a co-
monomer. Figure 3.4 shows these particles also had a slight increase (51 nm radius) over 
the acrylic acid particles, but were still close to 50 nm in radius. A further attempt to 
decrease the core particle size was also successful with pNIPMAm-co-AFA (pNIPMAm-
co-AFA #6, Figure 3.4). The particle size was decreased to 45 nm by increasing [BIS] 






















1 pNIPMAm- 96% BIS- 2% AAc- 2% 4 4 70 N/A 
2 pNIPMAm- 96% BIS- 2% AAc- 2% 4 4 140 137 
3 pNIPMAm- 96% BIS- 2% AAc- 2% 6 6 140 60 
4 pNIPMAm- 96% BIS- 2% AAc- 2% 8 8 140 48 
5 pNIPMAm- 98% BIS- 2% AFA- 0.1 mM 8 8 140 51 










Figure 3.4. Particle sizes determined for the pNIPMAm core particle syntheses. Error 
bars do not indicate a standard deviation, but rather the total width of the differential 




A thin, hydrogel shell was added to the 57 nm-radius pNIPAm-co-AFA core 
particles using a total monomer concentration of 20 mM in the feed solution. The shell 
consisted of pNIPAm, BIS, and APMA. The shell synthesis is a seeded precipitation 
polymerization reaction. The core particles are heated well above the LCST and the 
deswollen particles act as nuclei onto which growing polymer can be added. The thin 
shell compresses the core particle, and upon reswelling, the particle is actually smaller in 
size. Our group has previously shown shell compression, wherein the thin shell does not 
allow a complete reswelling of the core.
[24]
 Figure 3.5 shows that the shell compression 
creates a particle that is 52 nm in radius, versus the 57 nm radius core. The addition of 
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Figure 3.5. Change in size of pNIPAm core particles versus pNIPAm core/shell particles. 




  In order to add a shell to the 51 nm-radius pNIPMAm-co-AFA core, the shell’s 
monomer concentration had to be increased from that of pNIPAm, to 50 mM. The shell 
consisted of pNIPMAm, BIS, and APMA. With the increase in monomer concentration, 
the particles did not see a dramatic compression as with the pNIPAm particles. 
Compression of the core most likely still occurs, but the increase in monomer 
concentration (and hence the increase in shell thickness) was enough to overtake the 
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amount of compression, and increase the total size of the particles. The pNIPMAm 
core/shell particles increased in size from 51 nm in radius for the core to 55 nm radius for 





Figure 3.6. Change in size of pNIPMAm core particles versus pNIPMAm core/shell 




Figure 3.7 shows turbidity curves measured for both pNIPAm and pNIPMAm 
core/shell particles. The pNIPAm core/shell particles exhibited an LCST of ~ 31 °C, 
while the pNIPMAm core/shell particles exhibited an LCST of ~ 44 °C. Both of these 
values were as expected given the literature precedent referenced above. Future studies 
will compare targeting efficiencies of both sets of particles, as pNIPAm core/shell 
particles will be mainly deswollen at 37 °C, while pNIPMAm core/shell particles will be 
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mainly swollen at 37 °C. The deswollen pNIPAm particles are hydrophobic, which can 
lead to the particles being taken up by the RES. The swollen pNIPMAm particles are 







Figure 3.7. Temperature-dependent turbidity measurements for (a) pNIPAm core/shell 




The core/shell particles are suitable for bioconjugation due to the amines 
incorporated in the shell. A variety of bioconjugation strategies can be used to create 
targeting moieties on the shell of the particles using pendant amines.
[29-32]
 In this case, we 
have used carbodiimide coupling to attach folic acid to the particles. Folic acid is 
biologically important, as it is needed by the body as vitamin B9. In addition, the folate 
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receptor is overexpressed in many tumor cells. This makes folic acid and its receptor a 
prime candidate for targeting studies. Figure 3.8 shows the incorporation of folic acid on 
the core/shell particles. Particles were conjugated with folic acid and cleaned several 
times by centrifugation to remove any free folic acid. Absorbance measurements for folic 
acid show a peak 285 nm. Unconjugated particles do not show this peak, while 
conjugated particles do show an absorbance peak at 285 nm, indicating folic acid has 
been conjugated to the particles. Future studies will use these bioconjugated core/shell 





Figure 3.8. Absorbance of free folic acid (red), and pNIPAm core/shell particles before 






 In this chapter, it has been shown that small, bioconjugated nanogels can be 
produced using a very straightforward synthetic approach. Through our synthetic 
methods, we have shown control over particle size, with the ability to synthesize a wide 
range of diameters. The particles are highly monodisperse at all sizes and core/shell 
compositions. The ability to incorporate acrylic acid in the core allows greater 
functionality among the particles (i.e. for additional chemoligations), while the AFA-
incorporated core allows fluorescent tracking. The incorporation of amines in the shell 
gives the particles multiple functionalities, allowing simple conjugation to acid groups 
present on a number of biologically important targeting moieties. We have illustrated this 
ability with the addition of folic acid to the particles in this contribution. The following 
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 CHAPTER 4 
 




Many different types of delivery vehicles have been explored for in vivo 
applications. Among these are liposomes
[1-5]





 For each of these, the same set of design rules tends to be 
followed. The aim of one of these rules is to have a long circulation time of the particles 
in the blood. To increase circulation time, the particles need to resist protein adsorption 
and opsonization, which leads to clearance by the reticuloendothelial system (RES).
[4, 22]
 
Particle surface characteristics can be designed to avoid the RES longer by increasing the 
hydrophilicity of the particles.  
Another important design feature of targeted delivery vehicles is size. Particles 
must be near 100 nm in diameter for efficient delivery through the vasculature for 
intravenous delivery applications.
[23-25]
 Particles that are this size are unable to penetrate 
healthy tissues, which have pore sizes of ~2 nm in the endothelia of blood vessels, and 
~6-nm pores in postcapillary venules.
[26]
 This pore size exclusion is not seen in tumor 
vasculature though. Pore sizes range from 100 to 780 nm in the leaky vasculature of 
tumors.
[26-28]
 The leakiness leads to the enhanced permeability and retention effect (EPR), 





Another important consideration for particle size is to avoid lymphatic drainage. Particles 
that are too small (tens of nm) tend to be rapidly cleared by this pathway.
[23-25]
 Particles 
in the range of 50-100 nm can efficiently avoid lymphatic drainage.
[23-25]
  
In an attempt to follow these design rules, researchers have utilized several 
structures as delivery vehicles. Many researchers have used liposomes to deliver 
materials
[1-5]
, but instability can make liposomes a less than ideal carrier system. Block-
co-polymer micelles have been investigated
[6-10]
, but toxicity issues hold this approach 
back. Difficult synthetic approaches make dendrimer carriers unsuitable for scalable 
manufacture of drug delivery devices.
[23, 32, 33]
  
For the applications in this chapter, nanogels will be investigated as delivery 
vehicles. As described in previous chapters, nanogels have unique features that lend the 
particles to many uses. Chapter 3 detailed nanogels composed of poly(N-
isopropylmethacrylamide) (pNIPMAm) have a lower critical solution temperature 
(LCST) ~44 ºC. Below this temperature, the particles are hydrophilic and swollen. Above 
this temperature, the water is expelled, due to an entropically-driven polymer phase 
separation.
[34-37]
 These particles are mainly swollen at body temperature (37 ºC). The use 
of pNIPMAm nanogels at 37 ºC would make the particles very hydrophilic, which could 
be advantageous in permitting longer circulation times in the body, as described earlier.  
 Another important design rule for delivery devices is to have a targeting moiety 
so particles can effectively reach their destination. For this investigation, we will utilize 
cell receptors for targeting. The Eph family of receptors and their ephrin ligands play 
important roles in neural development, vascular development, and are critical in 
pathological forms of angiogenesis.
[38]
 The erythropoietin-producing hepatocellular 
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(EphA2) receptor is expressed in the vasculature of human tumors. EphA2 is also up-
regulated in the cells of a number of tumors, including ovarian, prostate, breast, skin, 
colon, and esophageal cancers.  The ability to mimic an ephrin ligand would allow 
targeting of cancer cells through delivery vehicles. The Pasquale group has found a 
peptide mimic that binds EphA2 and stimulates it receptor tyrosine kinase activity.
[38]
 
This peptide mimic is twelve amino acids long, and has a sequence of 
YSAYPDSVPMMS. We have added a C-terminal cysteine for aiding in conjugation to 
core/shell nanogel particles (YSAYPDSVPMMSC) (the “YSA” peptide).  
The up-regulation of EphA2, combined with the EPR effect, could lead to 
targeting by anti-cancer drug containing vehicles. Nanogels designed around 100 nm in 
diameter could therefore be used as efficient delivery vehicles. Bioconjugation of the 
YSA peptide to the nanogels could then make these targeted delivery vehicles. In this 
work, we will describe the use of nanogels encapsulated with siGLO Red Transfection 
Indicator (siGLO), a non-targeted siRNA linked with the fluorophore DY-547, and their 
targeted delivery to cancer cells.  
 
4.2 Experimental Section 
 
4.2.1 Materials 






4.2.2 Nanogel core synthesis 
Nanogel core particles were synthesized by free-radical precipitation 
polymerization, as previously reported.
[39, 40]
 The molar composition was 98% N-
isopropylmethacrylamide (NIPMAm), 2% N,N’-methylenebis(acrylamide) (BIS), and 
0.1mM acrylamidofluorescein (synthesized previously).
[41]
 A total monomer 
concentration of 140 mM was used. Polymerizations were carried out in a three-neck 
round-bottom flask. A total of 8 mM sodium dodecylsulfate (SDS) was used to stabilize 
the reaction, while 8 mM ammonium persulfate (APS) was used to initiate the reaction. 
For the synthesis, 100 mL of a filtered, aqueous solution of NIPMAm, BIS, and SDS was 
added to the flask and heated to 70 ºC. The solution was purged with N2 gas and stirred 
vigorously until the temperature remained stable. The AFA was added and after 10 
minutes, the reaction was initiated by the addition of a 1-mL solution of 8 mM APS. The 
solution turned turbid, indicating successful initiation. The reaction was allowed to 
continue for 4 h under N2 gas. After the synthesis, the solution was filtered through a 
Whatman filter paper.  
 
4.2.3 Nanogel shell synthesis 
Core particles were used as seeds for the addition of a shell hydrogel. The detailed 
procedure of the shell synthesis has been reported previously.
[39, 40]
 Briefly, 10 mL of 
core nanogel solution, 2 mM SDS, and 35 mL of deionized H2O were added to a three-
neck round-bottom flask and heated under N2 gas to 70 ºC. Separately, a 50 mM mixture 
with the molar ratios of 97.5% NIPMAm, 2% BIS, and 0.5% APMA (Polysciences) were 
dissolved in 5 mL of deionized H2O. The solution was added to the three-neck round-
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bottom flask, and the temperature was allowed to stabilize at 70 ºC. The reaction was 
initiated by a 1 mL solution of 0.5 mM APS. The reaction proceeded for 4 h under N2 
gas. Following the synthesis, the solution was filtered through a Whatman filter paper. 
The particles were purified by centrifugation. 
 
4.2.4 YSA synthesis    
The YSA peptide (YSAYPDSVPMMSC) was synthesized using standard Fmoc 
chemistry as described previously
[42]
. Peptide synthesis was carried out by K.D. Clark, 
University of Georgia. Following synthesis, the resin-peptide was cleaved and 
deprotected for 4 h in reagent K after air-drying.  The peptide was purified using a series 
of 5 mL injections onto a preparatory HPLC column (10-m; particle size, 21.2 mm 25 
cm, Jupiter C18; Phenomenex Inc.) using HPLC-grade H2O and a linear gradient of 
acetonitrile (0–70 min, 10–80%) at 5 mL per min.  Both the acetonitrile and H2O 
contained 0.05% trifluoroacetic acid.  The desired peak was identified by matrix-assisted 
laser desorption ionization time-of-flight mass spectrometry, and the peaks from multiple 
runs were pooled, lyophilized, and stored at 4 ºC in solid form. On other occasions, the 
YSA peptide was also purchased from GenScript Corp.  
 
4.2.5 Peptide conjugation 
The YSA peptide or scrambled YSA peptide (GenScript) was conjugated to the 
nanogels via maleimide coupling to the cysteine residue on the C-terminal end of the 
peptide. A solution of EDC (Pierce) and NHS were added to ε-maleimidocaproic acid in 
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pH 6.0 MES buffer to activate the acid groups for 30 min at room temperature. This 
solution was then added to particles and reacted for 2 h on a shaker table. The particles 
were centrifuged to remove any unreacted material, and then the peptide was added to the 
particles and reacted overnight. Particles were then cleaned by centrifugation as described 
above.  
 
4.2.6 siGLO encapsulation  
A solution of siGLO (Dharmacon) was prepared in phosphate buffered saline 
(PBS). Lyophilized particles were dissolved in this solution at a concentration of 4 mg to 
250 µL of 20 mM siGLO and allowed to shake overnight. After shaking, the particles 
were then centrifuged to remove any free siGLO, and then followed by resuspension in 
PBS. 
 
4.2.7 Particle characterization 
4.2.7.1 Static light scattering 
 Multi-angle laser light scattering (MALLS; Wyatt Technology Corporation) 
detection following asymmetric field flow fractionation (AFFF) was performed as 
described in Chapter 3.2.3.1. 
 
4.2.7.2 Absorbance measurements  
A standard curve for increasing concentrations of siRNA was made by measuring 
the absorbance at 260 nm using a Shimadzu UV 1601 spectrophotometer. After siRNA 
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was encapsulated in the particles and the particles were then centrifuged, the absorbance 
of the supernatant was then measured to determine the amount taken up by the particles.  
 
4.2.7.3 Fluorimetry 
Particle LCST values were measured using a steady-state fluorescence 
spectrophotometer (Photon Technology International), equipped with a Model 814 PMT 
photon-counting detector as described in Chapter 3.2.3.2. 
 
4.2.8 Cell culture 
Hey cells were provided by Gordon W. Mills, Department of Molecular 
Therapeutics, the University of Texas, M. D. Anderson Cancer Center. Hey cells were 
cultured in RPMI 1640 (Mediatech) supplemented with 10% v/v heat-inactivated fetal 
calf serum (Invitrogen), 2 mM L-glutamine (Mediatech), 10 mM HEPES buffer 
(Mediatech), penicillin (100 U/ml), and streptomycin (100 µg/ml). Human umbilical vein 
endothelial cells (HUVEC) were purchased from Lonza. HUVECs were grown as 
adherent cultures in EGM-2 medium (Lonza) supplemented with penicillin (100 U/ml) 
and streptomycin (100 µg/ml) (Sigma).  All cells were grown under standard conditions 
(37 ºC, 5% CO2 humidified atmosphere) and were serially passaged following 
detachment with 0.25% trypsin plus EDTA. Passages two through eight were used to 





4.2.9 Particle/transfection experiments 
4.2.9.1 siGLO-encapsulated particle transfection 
Hey cells were plated onto an 8-well chamber slide (5 x 10
3
 cells/well) and 
allowed to adhere overnight at 37 ºC and 5% CO2. After washing the wells with PBS and 
replacing the media, siGLO-loaded/YSA-conjugated nanogels, unloaded YSA-
conjugated nanogels, pNIPMAm nanogels and siGLO only were added to wells. Cells 
were incubated with nanogels for 4 h. Cells were then washed with PBS, and media 
replaced. The cells were then fixed by adding paraformaldehyde for 30 min. The wells 
were then aspirated and the chamber removed. A cover slip was placed on the slide for 
microscopic imaging. 
 
4.2.9.2 Ephrin competition assay 
Hey cells were plated onto an 8-well chamber slide (5 x 10
3
 cells/well) and 
allowed to adhere overnight at 37 ºC and 5% CO2. After washing the wells with PBS and 
replacing the media, Ephrin was added to 4 of the wells, at a 1:10 ephrin volume to media 
volume dilution. To the ephrin containing wells, siGLO-loaded/YSA-conjugated 
nanogels were added to 2 wells, and unloaded pNIPMAm nanogels were added to 2 
wells. Two other wells were incubated with siGLO-loaded/YSA-conjugated nanogels, 
and the final 2 wells were untreated cells. Cells were incubated with nanogels for 4 h. 
Cells were then washed with PBS, and media replaced. The cells were then fixed by 
adding paraformaldehyde for 30 min. The wells were then aspirated and the chamber 




4.2.9.3 Scrambled peptide targeting  
Hey cells were plated onto an 8-well chamber slide (5 x 10
3
 cells/well) and 
allowed to adhere overnight at 37 ºC and 5% CO2. After washing the wells with PBS and 
replacing the media, scrambled YSA-conjugated nanogels, unloaded YSA-conjugated 
nanogels, and pNIPMAm nanogels were added to wells; 4 wells were untreated. Cells 
were incubated with nanogels for 4 h. Cells were then washed with PBS, and media 
replaced. The cells were then fixed by adding paraformaldehyde for 30 min. The wells 




 4.2.10 Confocal Microscopy   
A Zeiss LSM510 confocal microscope was used to take cell images. Cells were 
incubated with or without particles encapsulated with siGLO for 4 h. After 4 h, the cells 
were washed and then fixed on the slide. An Ar
+
 laser was used to excite the AFA in 
particles in the cells. A HeNe laser was used to excite the siGLO that was delivered to the 
cells by the particles. LSM510 software was used to view the images.   
 
4.3 Results and Discussion 
Small, monodispersed nanogels (~ 50-nm radius) were synthesized by free-radical 
precipitation polymerization. These nanogels were designed with a core/shell 
architecture, using N-isopropylmethacrylamide as the main monomer. The core contains 
4-acrylamidofluorscein (AFA) for visualization during cell studies. The shell contains N- 
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(3-aminopropyl) methacrylamide to provide chemical handles at the surface of the 
nanogels for bioconjugation. The use of pNIPMAm nanogels provides swollen particles 
at body temperature (37 ºC), as these particles have a LCST of around 44 ºC.  
 Lyophilized nanogels were dissolved in a concentrated solution of siGLO, and 
shaken overnight. The volume of solution is just enough to completely dissolve the 
nanogels, forcing the siGLO into the gels in a technique known as “breathing-in.” After 
overnight shaking, the nanogels are centrifuged and the supernatant aspirated to remove 
any non-encapsulated siGLO. The absorbance of the supernatant was measured to detect 
the amount of siGLO that was not encapsulated in the nanogels, and ~ 80-95% (by mass) 
of the siGLO in solution is retained in the particles. The absorbance measurements were 
compared to a standard curve of siGLO in solution.  
The siGLO-loaded nanogels were then incubated with Hey and BG-1 cells. Hey 
and BG-1 cells were incubated overnight in an 8-well chamber slide. Cells were 
incubated with siGLO-loaded/YSA-conjugated nanogels, unloaded YSA-conjugated 
nanogels, non-targeted pNIPMAm nanogels, or siGLO only for 4 h. The cells were then 
washed and the slides fixed for confocal microscopy imaging. Figure 4.1 shows cells 
targeted with YSA-conjugated nanogels show significant particle uptake (D-F), and cells 
incubated with siGLO-loaded/YSA-conjugated nanogels show significant uptake of 





Figure 4.1. Confocal microscopy images of Hey cells following exposure to siGLO-
loaded/YSA-conjugated nanogels. (A) shows the green (AFA) channel and (B) shows the 
red (siGLO) channel. (C) is an overlay of these channels. (D) shows the green channel 
and (E) shows red channel following exposure of Hey cells to unloaded YSA-conjugated 








Nanogel and siGLO uptake was higher in Hey cells versus BG-1 cells as Hey 
cells have 10-fold higher EphA2 receptor over BG-1 cells.  The same procedure was used 
as with Hey cells. Figure 4.2 shows siGLO-loaded/YSA-conjugated nanogels are taken 





Figure 4.2. Confocal microscopy images of BG-1 cells following exposure to siGLO-
loaded/YSA-conjugated nanogels. (A) shows the green (AFA) channel and (B) shows the 
red (siGLO) channel. (C) is an overlay of these channels. 
   
 
 For both Hey and BG-1 cells, non-targeted nanogels show very little cell uptake. 






shows unloaded pNIPMAm nanogels targeted to Hey cells. It appears that there is some 
non-specific uptake of the nanogels, but this amount is insignificant as compared to YSA-
conjugated nanogels. Similar results are seen with BG-1 cells targeted by unloaded 
pNIPMAm nanogels (image not shown). To ensure that siGLO could not enter the cells 
without a carrier, Hey and BG-1 cells were also incubated with the siGLO only. For both 





Figure 4.3. Confocal microscopy images of Hey cells following exposure to non-
targeting pNIPMAm nanogels. (A) shows the green (AFA) channel and (B) shows the red 








 While these results suggest that targeting of EphA2 receptor is the mode of entry 
for the nanogels, it was necessary to further explore cell uptake. To do this, Hey cells 
were pre-incubated with the natural ligand for EphA2, ephrin, before nanogel delivery. If 
cell uptake of nanogels is receptor-mediated, the uptake after cell exposure to ephrin 
should be greatly reduced, as the EphA2 receptor will be internalized and less available 
for nanogel uptake. Hey cells were incubated overnight in an 8-well chamber slide. To 2 
wells, 2 µg of ephrin was added, and the cells were incubated for 1 h. After ephrin 
incubation, siGLO-loaded/YSA-conjugated nanogels were added to the ephrin and non-
ephrin incubated wells. The cells were incubated for 4 h and then washed and the slide 
fixed for confocal microscopy imaging. Figure 4.4 A-C shows the cells incubated with 
ephrin. These wells do show some uptake of nanogels and siGLO after ephrin was added, 
but wells D-F show much brighter fluorescence for siGLO loaded nanogels added 
without ephrin, indicating higher uptake by the cells. These results suggest that nanogel 





Figure 4.4. Confocal microscopy images of Hey cells following exposure to siGLO-
loaded/YSA-conjugated nanogels after 1 h ephrin incubation. (A) shows the green (AFA) 
channel and (B) shows the red (siGLO) channel. (C) is an overlay of these channels. (D) 
shows the green channel and (E) shows red channel following exposure of Hey cells to 









The results shown in this chapter describe the efficient uptake of siGLO and 
delivery to cells by nanogels. Nanogels conjugated with YSA preferentially target the 
EphA2 receptor present on Hey and BG-1 cells, while the cells do not take up 
unconjugated nanogels as readily. The ability to encapsulate high concentrations of 
siGLO allows its delivery to the cells via the nanogels. The results also suggest that the 
uptake of targeted nanogels is receptor mediated, as the delivery of the natural ligand to 
EphA2 reduces uptake of the particles. The use of nanogels therefore has potential to be 
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CHEMOTHERAPEUTIC POTENTIAL OF PROTEIN 
KNOCKDOWN BY NANOGEL DELIVERY OF siRNA 
 
5.1 Introduction 
Genetic engineering is a field that has gained much interest in recent years as a 
way to treat disease. The goal of genetic engineering is to successfully transfer genetic 
information to targeted tissues, with the clinical goal of recovering a healthy tissue, or 
destroying an irreparably damaged one (e.g. as in cancer). This is not a simple 
proposition though, as naked genes are degraded by nucleases and not easily delivered 
across the cell membrane.
[1, 2]
 These issues lead to the need for an efficient delivery 
vehicle to successfully transport a therapeutic gene to its targeted site of interest. Genetic 
engineering can refer to gene delivery, as a way to gain function, or for tracking 
experiments by adding a gene that will express a protein such as green fluorescent 
protein.
[1, 2]
 Genetic engineering can also refer to a loss of function. Loss of function 




RNA interference (RNAi) is a relatively new approach to gene silencing in vitro 
and in vivo. This naturally occurring mechanism was discovered by Fire and Mello et al. 
in Nobel prize winning work first published in 1998.
[3]
 RNAi employs small 21-25 
nucleotide long double stranded RNAs (dsRNA) to lead to inhibition of gene expression. 
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These small RNAs are known as small interfering RNAs (siRNA). Gene silencing by 
siRNA begins by cleavage of the double stranded RNA to single strands by the enzyme 
Dicer. The single stranded RNAs are then assembled into the RNA Induced Silencing 
Complex (RISC), and lined up with a complementary sequence on the target mRNA.
[4]
 
The target mRNA can then be degraded, leading to gene silencing. The use of siRNA for 
therapeutic applications could therefore be very effective at specifically shutting down 
genes both in cell culture and in vivo.  
Artificial siRNA can be delivered to cells to get the same silencing response as 
naturally occurring RNA. The RNAi response is triggered by the presence of the dsRNA. 
However, the introduction of long dsRNA can lead to the initiation of the anti-viral 
interferon response and global protein expression shutdown.
[5]
 This response can be 
avoided though by delivering small double stranded siRNA. From this point, the siRNA 
interacts with Dicer and enters RISC.  
The delivery of siRNA across the cell membrane is a problem that has led to 
much research. The polyanionic nature of siRNA, due to the phosphates, along with its 
high molecular weight (~13 kDa), keeps the small RNAs from freely crossing the cell 
membrane.
[5]
 Therefore, a delivery system must be utilized to effectively target siRNA 
into the cell. These problems are part of a larger effort in the development of effective 
delivery vehicles for genetic information. Many non-viral transport have been developed 
to carry DNA or RNA to cells.
[1]
 One approach has been to covalently attach the genetic 
material to folate 
[6, 7]
 or peptides 
[8, 9]
 for cell targeting. However, these methods do not 
protect the naked genetic material from nucleases, so an optimal vehicle should act as a 
carrier that can shield the material from degradation. An approach taken by Kakizawa 
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and Kataoka has been to synthesize block-co-polymer micelles composed of poly-L-
lysine (PLL), poly(ethylenimine) (PEI), and poly(di-methylaminoethyl methacrylate) 
(PAMA) to encapsulate DNA.
[10]
 Perez et al. have used poly(lactic acid) (PLA)- 
poly(ethylene glycol) (PEG) polymer microspheres 
[11]
 while Dass has used liposomes to 
deliver DNA to cells.
[12]
   
One of the most popular methods for delivering siRNA has been the use of 
commercial lipid carriers. These carriers have been developed by several industrial 
companies, but have drawbacks such as toxicity issues and difficulties in cell targeting.
[13]
 
Therefore, researchers are looking to alternative delivery methods for siRNA as well. 
Schiffelers et al. have used an RGD (Arg-Gly-Asp peptide ligand)-PEG-PEI complex to 
target siRNA to tumor neovasculature. Song et al. used a protamine-antibody fusion 
protein using the Fab fragment of HIV-1 envelope antibody for siRNA delivery.
[14]
 
Another targeting motif has been the use of liposomes in the form of an immunoliposome 
complex in work performed by Pirollo et al.
[15]
    
While these siRNA carriers have shown certain degrees of success, there are still 
issues of toxicity and payload capacity. We have utilized nanogels to encapsulate and 
deliver siRNA to ovarian cancer cells. As described in previous chapters, nanogels 
composed of poly(N-isopropylmethacrylamide) (pNIPMAm) could be ideal delivery 
vehicles. The nanogels are swollen at body temperature, leading to high payload capacity 
and making the particles hydrophilic in nature, which could lead to longer circulation 
times. The conjugation of the YSA (YSAYPDMMSC) peptide to the nanogels 
preferentially targets the nanogels to the EphA2 receptor, as shown in Chapter 4, and 
non-targeted siRNA linked with a red dye can be effectively encapsulated and targeted to 
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Hey and BG-1 cells. This chapter will show that siRNA can be delivered to knockdown 
epidermal growth factor receptor (EGFR) expression. Knockdown of EGFR is non-lethal 
on its own, but has been shown to increase drug sensitivity to previously drug resistant 
ovarian carcinomas.
[16, 17]
 After delivery of siRNA to cancer cells to knockdown EGFR, 
we have treated the cells with taxol to determine the chemotherapeutic potential of the 
combination therapy approach. 
The targeting of EphA2 for particle uptake, combined with siRNA targeting 
EGFR for protein silencing is by design. It has been shown that EGFR can regulate 
EphA2 levels, as the activation of EGFR increases EphA2 mRNA levels.
[18]
 EphA2 is a 
direct transcriptional target of EGFR signaling in some cancer cells.
[19, 20]
 Therefore, the 
presence of EGFR in Hey cells leads to an increase in EphA2, making it an ideal target. It 
has also been shown that EphA2 localizes with EGFR at the cell membrane.
[18]
 EphA2 
also plays a role in cell migration induced by EGF. Knockdown of EphA2 inhibits EGF-
induced cell migration.
[18]
 Uptake of particles by the EphA2 receptor could therefore 
have the added benefit of inhibiting cell migration. All of these factors led to utilizing 
both receptors for this study.  
 
5.2 Experimental Section 
5.2.1 Materials 





5.2.2 Nanogel core synthesis 
Nanogel core particles were synthesized as described in Chapter 4.2.2. 
 
5.2.3 Nanogel shell synthesis 
Nanogel shell addition was performed as described in Chapter 4.2.3. 
 
5.2.4 Peptide conjugation 
The YSA peptide (GenScript or provided by K. D. Clark, University of Georgia) 
was conjugated to the nanogels via maleimide coupling to the cysteine residue on the C-
terminal end of the peptide. A solution of EDC (Pierce) and NHS was added to ε-
maleimidocaproic acid in pH 6.0 MES buffer to activate the acid groups for 30 min at 
room temperature. This solution was then added to particles and reacted for 2 h on a 
shaker table. The particles were centrifuged to remove any unreacted material, and then 
the peptide was added to the particles and reacted overnight. Particles were then cleaned 
by centrifugation as described above.  
 
5.2.5 siRNA encapsulation  
A solution of EGFR siRNA (Dharmacon) or siGLO (Dharmacon) was prepared in 
phosphate buffered saline (PBS). Lyophilized particles were dissolved in this solution at 
a concentration of 4 mg to 250 µL of 20 mM siRNA and allowed to shake overnight. 
After shaking, the particles were then centrifuged to remove any free siRNA, and then 
followed by resuspension in PBS. 
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5.2.6 Particle characterization 
5.2.6.1 Absorbance measurements  
Absorbance measurements were made using a Shimadzu UV 1601 
spectrophotometer, as described in Chapter 4.2.7.2. 
 
5.2.7 Cell culture 
Hey cells and human umbilical vein endothelial cells (HUVEC) were cultured as 
described in Chapter 4.2.8. 
 
5.2.8 Particle/transfection experiments 
5.2.8.1 Commercial agent transfection 
Hey cells were plated onto 6-well plates (5 x 10
5
 cells/well) and allowed to adhere 
overnight at 37 ºC and 5% CO2. For studies with a commercial transfection reagent, 
RNAiFect (Qiagen) was used. Before the transfection, 12 µL of 100 nmol/L siRNA was 
added to 73 µL of EC-R buffer. To this, 15 µL of RNAiFect was added. This solution 
was allowed to incubate at room temperature for 15 min, and then added to each well. 







5.2.8.2 siGLO-encapsulated particle transfection 
For protein level determination, Hey cells were plated onto 6-well plates (5 x 10
5
 
cells/well) and allowed to adhere overnight at 37 ºC and 5% CO2. Particles encapsulated 
with siGLO were added to the appropriate wells and allowed to incubate for 4 h. The 
wells were then aspirated and washed with PBS. Fresh medium was added and the cells 
were incubated at 37 ºC and 5% CO2 in wells for 72 h. Control wells were set up to 
include non-targeted pNIPMAm particles, unloaded YSA-conjugated particles, and 
untreated cells.  
 
5.2.8.3 EGFR-siRNA-encapsulated particle transfection 
Hey cells were plated onto 6-well plates (5 x 10
5
 cells/well) and allowed to adhere 
overnight at 37 ºC and 5% CO2. EGFR-siRNA encapsulated particles were added to the 
appropriate wells and allowed to incubate for 4 h. The wells were then aspirated and 
washed with PBS. Fresh medium was added and the cells were incubated at 37 ºC and 
5% CO2 in wells for 24, 48, 72, 96, and 120 h experiments. Control wells were set up to 
include non-targeted, siRNA-encapsulated pNIPMAm particles, unloaded YSA-
conjugated particles, unloaded pNIPMAm particles, and untreated cells.  
In order to transfect different concentrations of siRNA to the cells, the same 
loading procedure was used, but the concentration of particles delivered to each well was 
varied. The same concentration of siRNA-encapsulated particles as the time point 
experiments was added to a well. The concentration of the next 3 wells was reduced by 
10 fold each. After 4 h incubation with the particles, wells were cleaned and the medium 
replaced. The cells were then incubated for 72 h.  
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Nanogels were also targeted to human umbilical vein endothelial cells 
(HUVECs). HUVECs were plated onto an 8-well chamber slide (5 x 10
3
 cells/well) and 
allowed to adhere overnight at 37 ºC and 5% CO2. After washing the wells with PBS and 
replacing the media, YSA-conjugated nanogels and pNIPMAm nanogels were added to 
cells to incubate for 4 h, and wells were set up with untreated cells. Cells were then 
washed with PBS, and the media was replaced. The cells were then fixed by adding 
paraformaldehyde for 30 min. The wells were then aspirated and the chamber removed. 
A cover slip was placed on the slide for microscopic imaging. 
 
5.2.9 Toxicity Studies 
5.2.9.1 Trypan Blue Exclusion Assay 
 Hey cells were plated onto 6-well plates (5 x 10
5
 cells/well) and allowed to adhere 
overnight at 37 ºC and 5% CO2. The media was aspirated, and then wells were washed 
with PBS. The PBS was then aspirated and the media replaced.  Wells were set up at each 
of the 4 concentrations of siRNA-loaded nanogels used in the protein knockdown 
experiments, unloaded YSA-conjugated nanogels, and a well of untreated cells. The cells 
were incubated with the nanogels for 4 h. The wells were then aspirated, washed with 
PBS, and the media replaced. The cells were then incubated for 72 h to allow siRNA 
treatment to occur. After siRNA treatment, wells were aspirated, washed with PBS, and 
then aspirated again. A 1-mL solution of trypan blue was diluted to 4 mL in PBS, and 
400 µL added to each well. Each well was then viewed via optical microscopy to 
determine the number of stained (dead) cells.  
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5.2.9.2 Tox 8 Assay 
Hey cells were plated onto 96-well plates (1 x 10
4
 cells/well) and allowed to 
adhere overnight at 37 ºC and 5% CO2. The media was aspirated, and then wells were 
washed with PBS. The PBS was then aspirated and the media replaced. Wells were set up 
in triplicate to include each concentration of delivered siRNA-loaded nanogels, unloaded 
YSA-conjugated nanogels, unloaded pNIPMAm nanogels, and untreated cells. The cells 
were incubated with the nanogels for 4 h. The wells were then aspirated, washed with 
PBS, and the media replaced. The cells were then incubated for 72 h to allow siRNA 
treatment to occur.  
For the chemotherapy studies, wells were set up in triplicate to include 0 nM, 0.1 
nM, 1 nM, 10 nM, 100 nM, and 1000 nM taxol and the cells incubated for 4 d. The same 
concentrations of taxol were also used after nanogel delivery of siRNA at siRNA 
concentrations of 16 µg, 1.6 µg, 160 ng, and 16 ng. Cells were incubated with nanogels 
for 4 h, then the cells washed and media replaced.  At 48 h of siRNA treatment, cells 
were washed and media replaced, and then taxol was added.   
After these treatments, wells were aspirated, washed with PBS, and 100 µL of 
media was added back to the wells. To this, 10 µL of Tox 8 was added. Upon addition of 
Tox 8, the cells were incubated for 50 min. The fluorescence was then measured (λem = 
560 nm, λex = 590 nm) by a Spectramax Gemini Fluorescence Microplate Reader  






5.2.10 Confocal Microscopy   
A Zeiss LSM510 confocal microscope was used to take cell images as described 
in Chapter 4.2.10.  
 
5.2.11 Western blot analysis 
Hey cells were plated into 6 well plates (5x10
5
/ well) and allowed to adhere 
overnight at 37ºC, 5% CO2. Cells were lysed with 100 µl of lysis buffer (50 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA (Fisher), 2 mM EGTA (Fisher), 1 mM sodium 
orthovanadate, 2.5 mM sodium pyrophosphate, 1 mM β-gycerolphosphate, 1 mM 
phenylmethanesulfonyl fluoride, 10 µg/ml aprotinin, 10 µg/ ml leupeptin, 1% Triton X-
100, and 5% glycerol), and the lysates were sonicated four times for 5 seconds each. The 
lysates were cleared by centrifugation at 11,000 rcf for 15 min at 4 ºC. To the lysates, 90 
µL of Laemmli 2X sample buffer was added and the samples were then heated to 90 ºC 
for 5 min. 
For whole cell lysates, the proteins were separated by SDS-PAGE and transferred 
onto nitrocellulose. The blots were blocked with either 5% nonfat dry milk (NFDM) or 
5% bovine serum albumin (BSA) in 10 mM Tris-buffered saline, pH 7.5 plus 1% Tween 
20 (BioRad) (TBST) for 1 hour at room temperature. Blots were probed with anti-EGF-r 
antibody (Cell Signaling, cat. no. 4405) or with anti-β-actin antibody (Chemicon, 
Mab1501) diluted in 5% NFDM or 5% BSA overnight, with shaking at 4 ºC. Blots were 
washed three times with TBST and probed with goat anti-rabbit IgG (Santa Cruz, sc-
2004) or with goat anti-mouse IgG (Santa Cruz, sc-2005) linked to horseradish 
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peroxidase (HRP). Bands were visualized on film (Pierce) using the ECL reagent, pico 
west (Pierce).   
 
5.3 Results and Discussion 
As described in previous chapters, pNIPMAm nanogels around 100 nm in 
diameter were synthesized.
[21]
 These particles have an LCST of ~ 44 ºC, so the nanogels 
will be mostly swollen at body temperature. In this swollen state, the nanogels should be 
ideal for encapsulation. The results in Chapter 4 show that siGLO can be efficiently 
encapsulated within the particles, with roughly 80-95 % of siGLO in solution (20 µM) 
being taken up by the nanogels.  
Since these high concentrations could be imbibed by the nanogels, it was 
necessary to have a better understanding of how long the siGLO would stay in the 
nanogels. A 1 mL solution of 20 µM siGLO was used to resuspend 9.0 mg of YSA-
conjugated nanogels. The nanogels were shaken overnight and then divided into six 150 
µL aliquots. The first of these samples was designated as timepoint 0 h. The sample was 
centrifuged and 10 µL of the supernatant was used for absorbance measurements. The 10 
µL of supernatant was diluted to 1 mL in water and the absorbance was measured. The 
same procedure was done for each sample, following at timepoints 1 h, 2 h, 4 h, 8 h, and 
24 h. The results are shown in Table 5.1. They show that at each timepoint, the amount of 
siGLO released is consistent and low, corresponding to less than 9 % siGLO loss for each 
sample. It is interesting to note that one of the highest amounts is actually timepoint 0 h. 
While the highest amount is the 24 h timepoint, it is just 2 % more siGLO than the lowest 
amount, timepoint 8 h. These small differences are most likely due to the nanogels being 
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near a saturation point, and small amounts of siGLO will remain in solution. It appears 





Table 5.1 Absorbance measurements of supernatant from siGLO-loaded nanogels. 
Timepoint Absorbance at 260 nm % siGLO loss 
0 h 0.054 8.2 
1 h 0.039 7.0 
2 h 0.048 7.7 
4 h 0.054 8.2 
8 h 0.038 6.8 




The successful delivery of siGLO via targeted nanogels to Hey and BG-1 cells 
(Chapter 4) led to the attempt to deliver siRNA targeting epidermal growth factor 
receptor (EGFR). The EGFR siRNA was encapsulated at similar rates to siGLO. For 
these attempts we used Hey cells. The siRNA was encapsulated in YSA-conjugated 
nanogels and non-conjugated pNIPMAm nanogels by the breathing-in technique. Hey 
cells were incubated in 6-well plates overnight. After removing the media and washing 
the wells with PBS, the media was replaced and then the cells were incubated with 
nanogels for 4 h. The media was then removed and the wells were washed with PBS. The 
media was then replaced, and time points of 24, 48, 72, 96, and 120 h were set up in 
separate wells. Controls included cells incubated with siRNA-loaded, non-conjugated 
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pNIPMAm nanogels, unloaded YSA-conjugated nanogels, unloaded pNIPMAm 
nanogels, and untreated cells. After the 4 h incubation time, the cells were incubated at 37 
ºC for the required time point, with controls incubating for 48 h. At each time, the media 
was removed and cells washed with PBS. The PBS was then aspirated, and the cells were 
lysed. Protein levels for EGFR were then measured by immunoblot. Figure 5.1 shows 
percent knockdown at each time point, with controls showing little knockdown. The 
results show an average of 3 blots, with error bars representing the standard deviation. 
The 24 h timepoint shows high error. This is due to one blot showing little knockdown at 
24 h. This could be due to error during development of the film, or it  could be that 
knockdown begins near the 24 h timepoint, and for this experiment, protein knockdown 
was not seen until after 24 h. Low levels of knockdown of EGFR by commercial 








Figure 5.1. The knockdown of EGFR by nanogel-delivered siRNA at 24, 48, 72, 96, and 
120 h incubation times. Controls shown are unloaded YSA-conjugated particles and 




 The knockdown achieved in Figure 5.1 was using very high concentrations of 
siRNA, up to 1000-fold higher than used with commercial transfection reagents. The next 
step was to determine if lower concentrations would still have the same protein 
knockdown effect. The same breathing-in technique was used to encapsulate the siRNA 
within the nanogels, using the same concentrations as the previous experiments. In order 
to reduce the concentration of delivered siRNA, the amount of nanogels delivered to each 
well was reduced 10 fold until reaching concentrations used by commercial transfection 
reagents. The experiments were carried out in the same manner as the time point studies, 
with the concentration studies using a 72 h incubation time. Significant knockdown is 
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seen at each of the three highest concentrations, as seen in figure 5.2. The concentrations 





Figure 5.2. Immunoblot showing EGFR knockdown by various concentrations of siRNA 
delivered via nanogels. “YSA” designates unloaded YSA-conjugated nanogels, while the 




 Along with successful transfection of Hey cells with siRNA via nanogels, it was 
necessary to determine the toxicity of the particles. Two different cell viability assays 
were performed on each concentration of siRNA delivered by nanogels. A trypan blue 
exclusion assay was performed first. Hey cells were incubated overnight in 6-well plates. 
The following day, nanogels were incubated with the cells. After 4 h, the wells were 
washed with PBS, then aspirated and the media replaced. The cells were then incubated 
for 72 h to complete the nanogel/siRNA treatment. The wells were then aspirated and 
cleaned with PBS. A 1 mL solution of trypan blue was diluted to 4 mL in PBS, and 400 
µL of this was added to each well. Dead cells will become stained by trypan blue as it the 
 
143 
dye can cross the ruptured cell membrane. Viewing several fields via optical microscopy 
showed no stained cells among any concentration of siRNA delivered by nanogels 
(results not shown). No stained cells were seen among unloaded, YSA-conjugated 
nanogels or pNIPMAm nanogels.  
The second cell viability assay was a Tox 8 viability/proliferation assay. This 
assay was also performed on each nanogel-delivered siRNA concentration. It is a 
resazurin-based assay that allows for spectrophotometric measurement of cell metabolic 
activity. Hey cells were incubated in 96-well plates overnight. Nanogel were then 
delivered to the cells for 4 h. Wells were then washed with PBS, and 100 µL of media 
was added to the wells. Figure 5.3 shows that spectrophotometric analysis of the wells 
reveals no statistically significant difference for any treatment versus untreated cells. 
Controls of unloaded, YSA-conjugated nanogels and pNIPMAm nanogels are also not 








Figure 5.3. Tox 8 assay on siRNA-loaded nanogel delivery to Hey cells. The fluorescence 
indicates cell activity.  Concentrations denote siRNA delivered by nanogels. Controls are 




To ensure that protein silencing was not a side-effect of the nanogels and was 
caused by the EGFR siRNA, a non-targeting siRNA was delivered. The siRNA used in 
this experiment was siGLO. The same procedure was used as with EGFR siRNA 
delivery. The concentration of siGLO corresponded to the highest amount used in the 
knockdown studies. Hey cells were incubated with the nanogels for 4 h, then the wells 
were washed and the media replaced. Protein levels were measured at 72 h. No 
knockdown of EGFR by siGLO was observed (results not shown).  
 With the successful knockdown of EGFR by nanogel delivery of siRNA, we next 
investigated the effects of taxol on the cells, with and without nanogel targeting. To 
determine the effects of taxol alone, Hey cells were incubated in a 96-well plate 
overnight. Taxol was then added to wells at concentrations of 0.1 nM, 1 nM, 10 nM, 100 
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nM and 1000 nM. After 4 d, a Tox 8 assay was performed. Figure 5.4 (black line) shows 
the concentration dependent cytotoxicity of taxol on Hey cells. Toxic effects were seen as 
taxol concentration was increased to 100 nM. To determine if EGFR knockdown by 
siRNA could increase sensitivity of the cells to taxol, siRNA-loaded nanogels at the 
previously discussed concentrations were added. The siRNA treatment proceeded for 48 
h before taxol was added. At 4 d, a Tox 8 assay was performed. Unfortunately, 
experimental error led to some inconsistencies in the results. However, this preliminary 
study shows promise. Interestingly, the best results were seen with 160 ng siRNA 
delivery by the nanogels. The results (Figure 5.4 red line) suggest that toxic effects may 
be seen at concentrations as low as 1 nM. These studies should be a major focus of future 










In this chapter, it has been shown that siRNA can be efficiently delivered to Hey 
cells via nanogels. Through the breathing-in method, high concentrations of siRNA can 
be encapsulated in the nanogels. Peptide conjugation of the nanogels allows targeting to 
ovarian cancer cells, and thus the delivery of siRNA. The siRNA knocks down EGFR 
expression at multiple timepoints and concentrations, as the nanogels are able to enter the 
cells within 4 h and deliver their payload. The delivery of siRNA-loaded nanogels shows 
no toxic effects compared to untreated cells. However, Hey cells seem to become more 
sensitive to taxol, if added after EGFR knockdown. This therapy should be further 
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Ag-ENCAPSULATED NANOGELS FOR IN VIVO IMAGING 
 
6.1 Introduction 
 Non-invasive bioimaging modalities, such as magnetic resonance imaging (MRI) 
or ultrasound, have led to significant developments in modern medicine.
[1]
 Techniques 
like these can lead to identification of abnormal tissue, disease diagnosis, and tracking 
disease progress. Optical imaging is a technique that offers complementary information, 
and leads to improved spatial resolution over ultrasound and MRI.
[2]
 Multidimensional 
optical imaging allows for identification and localization of different tissue types and can 
provide true 3-D images. However, a drawback for this technique exists as optical probes 
used for imaging must be appropriate for clinical use. Therefore, new optical probes must 
be developed for improvements to be seen with in vivo imaging.   
 In vivo tumor imaging has become a major and necessary tool in cancer diagnosis 
and research. The number of imaging systems and their applications has rapidly 
expanded over the last few decades.  Imaging systems can be grouped based on their 
spatial resolution as either macroscopic or microscopic, or they can be grouped by the 
information obtained, as anatomical, physiological, cellular, or molecular systems.
[3]
 




, offer anatomical 
and physiological information that are used both clinically and in research. Approaches at 







 Now approaches are 
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being combined to take advantage of the strengths of multiple techniques. These 
approaches, such as PET-MRI are being used to improve data visualization.
[26, 27]
  
 Fluorescence bioimaging is a fast growing technique that is being used both 
preclinically and clinically. Fluorescent markers can be combined with microscopic 
techniques to visualize multiple cells or molecules at the same time, or to view targets 
deep in tissues. Fluorescence approaches include fluorescence reflectance imaging (FRI) 
and tomographic reflectance.
[1]
 FRI approaches give a two-dimensional image and are 
limited to shallow tissue depths. Tomographic reflectance systems provide 3-D images, 
but complicated algorithms that construct the images have made these approaches slow to 
move into clinical use.
[2, 19-21]
 These drawbacks then lead to the need to improve 
development of molecular probes. Probes that emit in the red to near-IR region can lead 
to greater image depth, quantification, and, with the use of tunable probes, multi-color 
imaging. Improved probes can also lead to higher resolution, which can allow the 
visualization of small cancer foci that may not be seen by traditional approaches such as 
PET.  
 Recently, research has focused on delivery of metal nanoparticles for 
bioimaging.
[28-30]
 Several researchers have used gold nanoparticles for tumor modeling, 
which has advantages of biocompatibility, photostability, and ease of coating. However, 
the coating must provide enough coverage to prevent aggregation of the gold 
nanoparticles.
[29]
 Corr et al. have used the polyelectrolyte, polysodium-4-styrene 
sulfonate (PSSS), to produce stable magnetic nanoparticles suspensions in water.
[31]
 The 
suspensions were created by adding a solution of iron to PSSS. Composites of 1:2, 3:1, 
and 6:1 PSSS to magnetic iron nanoparticles were used to create a chain-like assembly of 
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magnetic nanoparticles. These composites showed good biocompatibility and potential 
for in vivo MRI agents. The drawbacks to this system are little knowledge of the system’s 
tissue localization, and lack of targeting. Chung et al. have modified silver nanoparticles 
with phosphoryl disulfides.
[32]
 Sodium borohydride was used to reduce the disulfide 
bonds and silver ions, which created nanoclusters as the thiol groups generated reacted 
with silver atoms. Phosphorylcholine and phosphorylethanolamine was used to make the 
particles biocompatible. These nanoclusters were shown to be taken up by platelets and 
fibroblast cells. This method also lacks targeting, and since the studies are in the early 
stages, much is still unknown about their potential as imaging agents. Khan has 
developed magnetically responsive microgels by embedding iron oxide nanoparticles in 
poly(N-isopropylacrylamide)-co-acrylic acid particles.
[33]
 A colloidal magnetic solution 
was added to a solution of pNIPAm, AAc and methylene bisacrylamide, and then the 
reaction was initiated with ammonium persulfate. The microgels were around 115 nm in 
diameter, and TEM shows the magnetic nanoparticles in the microgels. These particles 
could prove effective as contrast agents for MRI.  
 The results in this chapter describe the use of poly(N-isopropylmethacrylamide) 
nanogels for silver nanocluster delivery in vivo.  As described in previous chapters, the 
nanogels are effective at encapsulation and targeting in vitro.  We will investigate the 
ability of the nanogels to encapsulate the silver nanoclusters, and then target the nanogels 
to Matrigel
TM
 plugs in mice.  





6.2 Experimental Section 
6.2.1 Materials 
 All materials were purchased from Sigma-Aldrich unless otherwise noted. The 
monomers N-isopropylacrylamide (NIPAm) and N-isopropylmethacrylamide (NIPMAm) 
were recrystallized from hexane (J. T. Baker) before use. The cross-linker N,N’- 
methylenebis(acrylamide) (BIS), acrylic acid, N-(3-aminopropyl) methacrylamide 
hydrochloride (APMA) (Polysciences), ammonium persulfate (APS), sodium dodecyl 
sulfate (SDS), and phosphate buffered saline (PBS) were used as received. All water used 
in the experiments was distilled, and then deionized using a Barnstead E-pure system 
operating at a resistance of 18 MΩ.  A 0.2 µm filter was used to remove particulate 
matter.  For peptide conjugation, the YSA peptide (YSAYPDSVPMMSC) (Genscript), 1-
ethyl-3-methyl-(3-dimethylaminopropyl)carbodiimide (EDC) (Pierce),  and dimethyl 
sulfoxide (DMSO) (Fisher) were used. The fluorescent monomer 4-
acrylamidofluorescein (AFA) was synthesized via a previously reported procedure.
[34]
 
Silver nanoclusters (Ag nanodots) in solution were synthesized by Sungmoon Choi in 
Robert M. Dickson’s lab, Department of Chemistry, Georgia Tech.  The Ag nanodots are 
composed of fewer than ten Ag atoms, stabilized by short, single stranded DNA strands. 
The Ag nanodots were provided in 250 µL aliquots (300 nM). 
 
6.2.2 Nanogel core synthesis 




6.2.3 Nanogel shell synthesis 
Nanogel shell addition was performed as described in Chapter 4.2.3. 
 
6.2.4 Peptide conjugation 
The YSA peptide was conjugated to the nanogels via maleimide coupling to the 
cysteine residue on the C-terminal end of the peptide. A solution of EDC (Pierce) and 
NHS were added to ε-maleimidocaproic acid to activate the acid group for 30 min. This 
solution was then added to particles and reacted for 2 h on a shaker table. The particles 
were centrifuged to remove any unreacted material, and then the peptide was added to the 
particles and reacted overnight. Particles were then cleaned by centrifugation as described 
above.  
 
6.2.5 Ag nanodot encapsulation 
Lyophilized particles were dissolved in a solution of Ag nanodots at a 
concentration of 4 mg to 250 µL of 300 nM nanodots and allowed to shake overnight. 
After shaking, the particles were then centrifuged to remove any free Ag nanodots, 
followed by resuspension in 0.5 mL PBS.  
 
6.2.6 Static light scattering 
Multi-angle laser light scattering (MALLS; Wyatt Technology Corporation) 
detection following asymmetric field flow fractionation (AFFF) was performed as 
described in Chapter 3.2.3.1. 
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6.2.7 Fluorescence microscopy 
 Fluorescence microscopy was used to image nanogels and Ag nanodots in 
solution and targeted Matrigel
TM
 plugs. An Olympus IX 70 inverted microscope equipped 
with a Mercury Arc lamp was used. An Olympus 100x UplanFl 1.30 NA oil immersion 
objective was used for imaging. Images were captured with a Cooke Cooporation 
Pixelfly color CCD camera. For observation of green fluorescence, a 40 nm band pass 
filter centered at 470 nm for excitation was used with a 515 nm long pass filter.  To 
visualize red fluorescence, a 50 nm band pass filter centered at 535 nm for excitation was 
used with a 590 long pass filter for emmision. 
 
 6.2.8 Targeting to Matrigel
TM
 plug 
All in vivo experiments were performed by Erin B. Dickerson, Department of 
Biology, Georgia Tech. Matrigel
TM
 (250 µL) was injected subcutaneously over the right 
flank of 8-12 week old female nu/nu mice and permitted to solidify.  Subsequently (after 
30–60 min), mice were anesthesized and a small (0.3-0.5 cm) nick was made in the skin 
using a #15 surgical blade. A smaller nick was then made in the Matrigel
TM
 plug. A 
sterilized polyvinyl sponge (2 x 2 x 1.5 mm) containing approximately 10
5
 Hey or 
OVCAR-3 ovarian tumor cells was introduced through the nick in the Matrigel
TM
 and 
placed in the center of the plug using forceps.  The wound was closed with a suture. Mice 
were observed after 24 h to monitor condition of the wound.  Mice were injected via the 
tail vein with 800-1000 µg of nanogel particles in a volume of 200 µL.  Nanogels were 
allowed to circulate for the times indicated, and the plugs were recovered.  Plugs were 
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stored in formalin and vessels containing nanogels were visualized under fluorescent 
light. 
 
6.3 Results and Discussion 
 As described in the previous chapters, pNIPMAm core/shell nanogels were 
synthesized by free-radical precipitation polymerization. These nanogels were near 100 
nm in diameter, for efficient delivery through the vasculature and uptake by cells.
[35]
 The 
nanogels were conjugated with the YSA peptide in order to target the particles to the Hey 
or OVCAR-3 cells and new vasculature forming in the Matrigel
TM
 plug, which have the 
EphA2 receptor, the target of YSA.  
 The nanogels were lyophilized in preparation for Ag nanodot encapsulation. The 
Ag nanodots were supplied by the Dickson lab at Georgia Tech in 250 µL aliquots at a 
concentration of 300 nM. The Ag nanodots used in this study emitted in the red region of 
the spectrum at ~ 600 nm. To encapsulate the Ag nanodots, the nanogels were dissolved 
in the solution of nanodots and shaken overnight. The nanogels were centrifuged to 
remove any unencapsulated Ag nanodots, and then resuspended in PBS. To determine 
whether the Ag nanodots were encapsulated, fluorescence microscopy was done to image 
both the nanogels and nanodots. Particles were diluted at 1:200, and then dried on a 
coverslip. Figure 6.1 shows images for both green and red emission from the same field 
of view on a fluorescent microscope. It shows that both the red (Ag nanodots) and green 
(AFA from nanogels) overlay each other, suggesting that the Ag nanodots are localized in 
the nanogels. The encapsulation of the Ag nanodots most likely occurs due to two 
reasons. The solution volume is just enough to dissolve the entire mass of particles. The 
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solution becomes very viscous, so the particles are forced to take up whatever is in 
solution. With the particles taking up the nanodots, they are then held in by hydrogen 
bonding. The amide groups of the nanogels offer multiple opportunities for hydrogen 



















Figure 6.1.  Fluorescence microscopy image of Ag nanodot encapsulated nanogels at day 


















We next wanted to see how efficiently the nanogels held the Ag nanodots. After 
the initial encapsulation, unused particles were stored in the dark at 4 ºC for 5 d. The 
particles were once again centrifuged to remove any Ag nanodots that were not 
encapsulated. Figure 6.2 again shows the green and red emitting fluorescent images of 
the particles. Once again, it is seen that the Ag nanodots are overlayed with the nanogels, 


































Figure 6.2. Fluorescence microscopy image of Ag nanodot encapsulated nanogels at day 















After it was determined that the Ag nanodots could be efficiently encapsulated in 





 was injected into mice subcutaneously, and allowed to solidify. Then, a 
sponge containing either Hey or OVCAR-3 cells was introduced into a nick cut into the 
plug. After closing the suture and observing the wound, the mice were injected with a 
solution of Ag nanodot-encapsulated YSA-conjugated nanogels or Ag nanodot-
encapsulated pNIPMAm nanogels via the tail vein. Nanogels were allowed to circulate 
for 2 h, at which point the Matrigel
TM
 plugs were removed and imaged. Figure 6.3 shows 
the fluorescence from the nanogels and Ag nanodots in the vasculature of the plug. The 
top panel shows the dual fluorescence image. The vasculature shows bright green 
fluorescence, indicating the presence of nanogels. There are also some spots of yellow, 
indicating an overlay of green and red fluorescence. This suggests that nanogels 
containing Ag nanodots are present in the Matrigel
TM
 plug. The bottom panel is red 
fluorescence, which shows a similar pattern to the green fluorescence. This red 
fluorescence is indicative of the Ag nanodots being present in plug. Future studies should 
be done to increase the Ag nanodot concentration and therefore the signal to background 
in these images. For these studies, similar results were seen among both the YSA-
conjugated and pNIPMAm nanogels. This is most likely due to vasculature leakiness, but 


















Figure 6.3. Fluorescence microscopy image of Matrigel
TM
 plug. Panel A shows dual  





Figure 6.4 shows another dual fluorescence image of the Matrigel
TM
 plug. This 
image shows the vasculature of the plug in more detail. Once again, there is bright 
fluorescence in the vessels, indicating very effective targeting of the nanogels to the 
Matrigel
TM











Figure 6.4. Dual fluorescence microscopy image of vessels in Matrigel
TM





 The results in this chapter show that targeted nanogel delivery in vivo holds 
promise as a bioimaging technique. As shown in previous chapters, nanogels are proving 
to be very effective encapsulation entities. This trend has continued with the 
encapsulation of Ag nanodots. The nanogels effectively hold the Ag nanodots for at least 
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5 d. Chapters 4 and 5 showed that YSA-conjugated nanogels also effectively target the 
EphA2 receptor on Hey cells. We have also targeted the nanogels to Hey cells and 
neovasculature in vivo, as they both have EphA2 receptor. However, unconjugated 
nanogels also seem to localize in the MatrigelTM plugs. This is most likely due to the 
leakiness of vasculature growing into the plugs. While these results are very preliminary, 
Ag nanodot encapsulated nanogels could show promise as imaging agents. Future studies 
should continue in order to increase Ag nanodot concentration and gain a better 
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For some of the projects listed in previous chapters, a great deal could still be 
learned by continuing on the work. We will now look at the directions these projects 
could be taken.  
 
● In Chapter 2, the many uses of AFFF-MALLS was discussed. One can envision a 
wide array of characterizations that could be done on the microgels synthesized in the 
Lyon group. One simple use that has not been explored yet is to measure the mass of the 
nanogels used in the targeted delivery projects discussed in this thesis. This could be 
helpful in many ways, such as determining the amount of encapsulated materials in the 
particles. Changes in mass after encapsulation could show how much material is in the 
particles, and then as the material is released, the mass should change again, giving an 
idea of release rate.  
Another future use of the AFFF-MALLS could be to study degradable microgels. 
Degradable microgels could be very useful for drug delivery. By making particles 
biodegradable, a drug could be delivered to its target site, then the particles degraded for 
easy removal from the body. The use of AFFF-MALLS could allow for the study of 
degradation by determining shape and mass of the particles. It would be interesting to 
watch the changes in shape as particles are degrading. Also, one can envision a decrease 
in mass as determined by AFFF-MALLS as particles degrade.  
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● In Chapters 4 and 5, we looked at siRNA encapsulation in nanogels, as well as the 
targeted delivery of the siRNA to cancer cells. This work has moved past its early stages, 
but there are still many more experiments that can be done. While we have shown 
significant protein knockdown of EGF receptor, it would appear that other proteins could 
also be silenced. The knockdown of certain proteins can be beneficial as therapeutic 
agents, so it could be interesting to see if nanogel delivery of siRNA could be as effective 
with some of these proteins.  
Another important experiment would be to determine if protein knockdown could 
be achieved in vivo by siRNA-loaded nanogels. While we have seen results that suggest 
nanogels can be targeted in vivo with no immediately obvious toxic effects (Chapter 6), 
the delivery of siRNA in mice has not been attempted. The concerns with in vivo delivery 
of siRNA would be if the particles hold onto the siRNA long enough for it to be delivered 
to its target, and if the particles would hinder nuclease degradation of the siRNA in the 
body.  
 Perhaps the most important experiment left to be done in this project is to do the 
chemotherapeutic studies once more to correct for the experimental error that occurred 
previously. Delivering siRNA via nanogels to cancer cells and following with Taxol 
treatment seems very promising so far as a chemotherapeutic technique. Correcting the 
error will give a clearer picture for how the cells respond at each concentration of siRNA 
delivered.  
 
● Chapter 6 dealt with silver nanodot-encapsulated nanogel delivery in vivo. The 
work in this chapter is in its infancy.  The results shown were with one set of Ag nanodots 
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that emit at ~ 600 nm. Our results suggest that nanogel efficiently hold onto the Ag 
nanodots, and can be targeted in mice. The next step in this project is to increase the 
concentration of Ag nanodots in the nanogels. This should be accomplished by simply 
increasing the Ag nanodots in solution before encapsulation in the nanogels.  
 The Dickson group at Georgia Tech has developed many different wavelength 
emitting Ag nanodots between 600-900 nm. Future studies should be done to show that 
Ag nanodots throughout this region can be efficiently encapsulated and retain their 
optical properties. If the Ag nanodot optical properties are not affected, more in vivo 
targeting studies should be done. Other future studies will be to continue to optimize both 
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